Renovare Environmental (RENO) 10-Q 19 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 06, 2019
Document and Entity Information
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	0001590383
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		17,245,344
Entity Emerging Growth Company	false
Entity Small Business	true

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue
Total revenue	$ 1,426,775	$ 1,088,082	$ 3,212,689	$ 2,642,946
Operating expenses
Selling, general and administrative	1,449,545	1,744,570	5,450,282	5,024,406
Depreciation and amortization	611,368	123,264	1,350,780	354,389
Total operating expenses	3,042,020	2,265,360	8,674,904	6,378,781
Loss from operations	(1,615,245)	(1,177,278)	(5,462,215)	(3,735,835)
Other (income) expenses
Gain on sale of affiliate investment	(562,617)	0	(562,617)	0
Equity loss in affiliate	0	179,041	0	371,531
Interest income	(46,180)	0	(46,180)	0
Interest expense	979,202	593,041	2,281,071	1,878,596
Expense incurred in warrant valuation and conversions	49,160	47,767	49,160	6,727,929
Total other (income) expenses	419,565	819,849	1,721,434	8,978,056
Net loss	(2,034,810)	(1,997,127)	(7,183,649)	(12,713,891)
Net loss attributable to non-controlling interests	(728,337)	0	(1,859,069)	0
Net loss attributable to Parent	(1,306,473)	(1,997,127)	(5,324,580)	(12,713,891)
Other comprehensive income (loss)
Foreign currency translation adjustment	(32,676)	3,820	(37,873)	27,740
Comprehensive loss	(1,339,149)	(1,993,307)	(5,362,453)	(12,686,151)
Net loss attributable to Parent	(1,306,473)	(1,997,127)	(5,324,580)	(12,713,891)
Preferred stock dividends	(255,847)	(130,794)	(548,075)	(365,970)
Deemed dividend on down round feature	(405,324)	0	(405,324)	0
Net loss - common shareholders	$ (1,967,645)	$ (2,127,921)	$ (6,277,979)	$ (13,079,861)
Net loss per common share - basic and diluted	$ (0.13)	$ (0.15)	$ (0.41)	$ (0.99)
Weighted average number of common shares outstanding - basic and diluted	15,649,174	14,575,375	15,134,301	13,257,303
HEBioT (related entity)
Revenue
Revenue	$ 609,905	$ 0	$ 886,947	$ 0
Operating expenses
Cost of revenue	786,680	0	1,309,176	0
Rental, service and maintenance [Member]
Revenue
Revenue	489,555	469,978	1,426,193	1,369,314
Operating expenses
Cost of revenue	176,651	241,875	508,164	644,832
Equipment sales [Member]
Revenue
Revenue	62,565	282,246	137,799	547,735
Operating expenses
Cost of revenue	17,776	155,651	56,502	355,154
Management advisory and other fees (related party) [Member]
Revenue
Revenue	$ 264,750	$ 335,858	$ 761,750	$ 725,897

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash	$ 3,434,089	$ 2,410,709
Restricted cash	1,128,716	4,195,148
Accounts receivable, net (related entity $831,274 as of September 30, 2019)	1,520,001	403,298
Inventory	429,198	499,848
Prepaid expenses and other current assets	169,232	66,425
Total Current Assets	6,681,236	7,575,428
Restricted cash	2,544,948	2,520,523
Equipment on operating leases, net	1,677,114	1,748,887
Equipment, fixtures and vehicles, net	34,094	49,028
HEBioT facility, net	36,806,051	33,104,007
Operating lease right of use assets	970,895	0
Investment in unconsolidated affiliates		1,687,383
MBT facility development and license costs	8,058,767	8,475,408
Goodwill	58,000	58,000
Other assets	58,949	97,433
Total Assets	56,890,054	55,316,097
Current Liabilities:
Line of credit, net of financing costs of $21,659 and $30,670 as of September 30, 2019 and December 31, 2018, respectively	1,478,340	1,469,330
Advance from related party	210,000	0
Accounts payable	4,200,518	1,310,998
Accrued interest payable	705,384	959,927
Accrued expenses and liabilities	818,085	3,354,124
Deferred revenue	91,228	98,596
Customer deposits	44,792	7,683
Note Payable	100,000	0
Current portion of WV EDA Senior Secured Bonds payable	1,390,000
Long-term debt, current portion	5,863	9,165
Total Current Liabilities	9,044,210	7,209,823
Note payable		100,000
Junior note due to related party, net of unamortized discounts of $102,263 and $118,266 as of September 30, 2019 and December 31, 2018, respectively	942,214	926,211
Accrued interest (related party)	1,390,380	1,305,251
WV EDA Senior Secured Bonds payable, net of financing costs of $1,892,623 and $1,914,098 as of September 30, 2019 and December 31, 2018, respectively	29,717,377	31,085,902
Senior Secured Note, net of financing costs of $125,295 and $160,017 and unamortized discounts of $793,758 and $988,678, as of September 30, 2019 and December 31, 2018, respectively	4,080,947	3,851,305
Non-current lease liabilities	913,367
Long-term debt, net of current portion	9,262	12,806
Total Liabilities	46,097,757	44,491,298
Series A redeemable convertible preferred stock, 333,401 shares designated and issued, and 145,312 outstanding as of September 30, 2019 and December 31, 2018	726,553	816,553
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, Value, Issued
Common stock, $0.0001 par value, 50,000,000 shares authorized, 17,163,400 and 14,802,956 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	1,717	1,480
Additional paid in capital	49,088,693	43,452,963
Accumulated deficit	(50,464,920)	(44,594,385)
Accumulated other comprehensive income	42,894	5,021
Stockholders' equity attributable to Parent	3,922,118	3,405,551
Stockholders' equity attributable to non-controlling interests	6,143,626	6,602,695
Total Stockholders' Equity	10,065,744	10,008,246
Total Liabilities and Stockholders' Equity	56,890,054	55,316,097
Series B Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	0	0
Series C Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	3,050,142	3,050,142
Series D Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	1,505,262	0
Series E Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	$ 698,330	$ 1,490,330

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred stock, Designated shares	3,179,120	3,159,120
Preferred Stock, Shares Issued	1,922,603	1,903,753
Preferred Stock, Shares Outstanding	856,181	1,155,333
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	17,163,400	14,802,956
Common stock, shares outstanding	17,163,400	14,802,956
Debt Issuance Costs, Current, Net	$ 21,659	$ 30,670
Accounts Receivable, Related Parties, Current	831,274
Accounts Payable, Related Parties, Current	1,563,705
Junior Notes [Member]
Due to Related Parties, Noncurrent	102,263	118,266
Senior Notes [Member]
Debt Issuance Costs, Noncurrent, Net	125,295	160,017
Debt Instrument, Unamortized Discount, Noncurrent	793,758	988,678
WV EDA SENIOR NOTES [Member]
Debt Issuance Costs, Noncurrent, Net	$ 1,892,623	$ 1,914,098
Series A Redeemable Convertible Preferred [Member]
Preferred stock, Designated shares	333,401	333,401
Series B Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,111,200	1,111,200
Preferred Stock, Shares Issued	428,333	428,333
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,000,000	1,000,000
Preferred Stock, Shares Issued	427,500	427,500
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred stock, Designated shares	20,000	20,000
Preferred Stock, Shares Issued	18,850	0
Preferred Stock, Shares Outstanding	18,850	0
Series E Convertible Preferred Stock [Member]
Preferred stock, Designated shares	714,519	714,519
Preferred Stock, Shares Issued	714,519	714,519
Preferred Stock, Shares Outstanding	264,519	564,519

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows used in operating activities:
Net loss	$ (7,183,649)	$ (12,713,891)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	1,350,780	354,383
Provision for bad debts	45,000	21,355
Share based employee compensation	741,188	485,244
Interest resulting from amortization of financing costs and discounts	333,782	1,318,895
Gain on sale of affiliate investment	(562,617)	0
Equity loss in affiliate	0	371,531
Interest resulting from warrants valued upon conversion of host debt instruments	0	6,424,970
Warrants modification	49,160	0
Loss resulting from abandonment of MBT site	346,654	0
Changes in operating assets and liabilities	(1,137,810)	(648,717)
Net cash used in operating activities	(6,017,512)	(4,386,230)
Cash flows used in investing activities:
Construction in-progress and purchases of equipment, fixtures and vehicles	(4,619,883)	(8,944)
Proceeds from sale of investment in affiliate	2,250,000	0
MBT facility development costs incurred	(59,013)	(328,718)
MBT facility development costs refunded	66,000	0
Net cash used in investing activities	(2,362,896)	(337,662)
Cash flows from financing activities:
Proceeds from common stock issuance, net of offering costs	3,035,557	0
Proceeds from issuance of senior secured credit facility and common stock	0	5,000,000
Repayment of line of credit facility	0	(2,463,736)
Proceeds from new line of credit facility	0	1,000,000
Exercise of employee stock options	0	61,976
Proceeds from the sale of Series D convertible preferred stock units	1,772,500	0
Financing costs incurred	(62,151)	(237,187)
Repayments of long-term debt	(6,846)	(6,629)
Proceeds from the subscription of Series B convertible preferred stock and warrants	0	1,125,000
Affiliate investment in subsidiary	1,400,000	0
Redemption of Series A preferred stock	0	(317,000)
Advance from related party, net	210,000	0
Related party:
Net cash provided by financing activities	6,349,060	4,162,424
Effect of exchange rate on cash	12,721	44,759
Net change in cash (restricted and unrestricted)	(2,018,627)	(516,709)
Cash - beginning of period (restricted and unrestricted)	9,126,380	901,112
Cash - end of period (restricted and unrestricted)	$ 7,107,753	$ 384,403

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]Series B Preferred Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series D Preferred Stock [Member]	Preferred Stock [Member]Series E Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]Series A preferred stock [Member]	Common Stock [Member]Series B Preferred Stock [Member]	Common Stock [Member]Series E Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]Series A preferred stock [Member]	Additional Paid in Capital [Member]Series B Preferred Stock [Member]	Additional Paid in Capital [Member]Series C Preferred Stock [Member]	Additional Paid in Capital [Member]Series D Preferred Stock [Member]	Additional Paid in Capital [Member]Series E Preferred Stock [Member]	Additional Paid in Capital [Member]	Accumulated Comprehensive Other Loss [Member]Series B Preferred Stock [Member]	Accumulated Comprehensive Other Loss [Member]	Accumulated Deficit [Member]Series B Preferred Stock [Member]	Accumulated Deficit [Member]	Non-Controlling Equity Interest [Member]	Series A preferred stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Series E Preferred Stock [Member]	Total
Balance at Dec. 31, 2017	$ 699,332						$ 960				$ 17,752,990					$ (38,590)		$ (29,431,416)				$ (11,016,724)
Balance (in shares) at Dec. 31, 2017	160,000						9,598,208
Issuance of registered common shares, net of offering costs	$ 1,068,039	$ 3,050,142									273,626	$ 1,360,681										1,341,665	$ 4,410,823
Issuance of registered common shares, net of offering costs (in shares)	268,333	427,500
Issuance of preferred stock	$ 1,068,039	$ 3,050,142									273,626	$ 1,360,681										1,341,665	$ 4,410,823
Issuance of preferred stock (in shares)	268,333	427,500
Preferred Stock Conversion							$ 330				9,090,045											9,090,375
Preferred stock dividends															$ 299,012				$ (365,970)							$ (66,958)
Common stock issued for acquisition of Gold Medal Group									$ 50						2,249,950											2,250,000
Preferred Stock Conversion (in shares)							3,304,140
Common stock issued for acquisition of Gold Medal Group (in shares)									500,000
Share-based employee and director compensation															485,244											485,244
Exercise of employee options									$ 2						61,975											61,977
Exercise of employee options (shares)									16,527
Share-based professional services compensation									$ 10						125,323											125,333
Share-based professional services compensation (in shares)									96,179
Conversion of debt into common stock (in shares)							3,304,140
Interest on converted debt in common stock						$ 20				$ 915,680											$ 915,700
Interest on converted debt in common stock (in shares)						196,050
Conversion of preferred stock into common stock	$ (1,767,371)					$ 9	$ 48			433,436	$ 1,767,323										433,445	$ 0
Conversion of preferred stock into common stock (in shares)	(428,333)					96,320	480,067
Common stock issued in connection with debt financings									$ 32						1,212,089											1,212,121
Common stock issued in connection with debt financings (in shares)									320,000
Warrants valued in connection with debt conversions and amendments									$ (2)						(6,424,968)											(6,424,970)
Warrants valued in connection with debt conversions and amendments (in shares)									23,243
Foreign currency translation adjustment																	$ 27,740									27,740
Net loss																			(12,713,891)							(12,713,891)
Net Loss																										0
Balance at Sep. 30, 2018					$ 3,050,142				$ 1,463						42,452,342		(10,850)		(42,511,277)							2,981,820
Balance (in shares) at Sep. 30, 2018					427,500				14,630,734
Balance at Jun. 30, 2018					$ 3,050,142				$ 1,453						41,593,223		(14,670)		(40,383,356)							4,246,792
Balance (in shares) at Jun. 30, 2018					427,500				14,531,152
Preferred stock dividends															108,043				(130,794)							(22,751)
Share-based employee and director compensation															330,331											330,331
Exercise of employee options									$ 2						61,975											61,977
Exercise of employee options (shares)									16,527
Share-based professional services compensation									$ 3						125,330											125,333
Share-based professional services compensation (in shares)									31,179
Conversion of preferred stock into common stock						$ 5				233,440											233,445
Conversion of preferred stock into common stock (in shares)						51,876
Foreign currency translation adjustment																	3,820									3,820
Net loss																			(1,997,127)							(1,997,127)
Net Loss																										0
Balance at Sep. 30, 2018					$ 3,050,142				$ 1,463						42,452,342		(10,850)		(42,511,277)							2,981,820
Balance (in shares) at Sep. 30, 2018					427,500				14,630,734
Balance at Dec. 31, 2018					$ 4,540,472				$ 1,480						43,452,963		5,021		(44,594,385)							3,405,551
Balance (in shares) at Dec. 31, 2018					992,019				14,802,956
Issuance of registered common shares, net of offering costs			$ 1,505,262						$ 188				$ 267,238		3,035,369									$ 1,772,500		3,035,557
Issuance of registered common shares, net of offering costs (in shares)			18,850	(300,000)				300,000	1,877,666
Issuance of preferred stock			$ 1,505,262						$ 188				$ 267,238		3,035,369									1,772,500		3,035,557
Issuance of preferred stock (in shares)			18,850	(300,000)				300,000	1,877,666
Preferred Stock Conversion				$ (792,000)				$ 30						$ 791,970											$ 0
Preferred stock dividends									$ 3						49,997				(140,631)							(90,631)
Preferred stock dividends (in shares)									27,778
Share-based employee and director compensation															741,188											741,188
Issuance of restricted stock									$ 11						205,489											205,500
Issuance of restricted stock (shares)									105,000
Conversion of preferred stock into common stock						$ 5				89,995											90,000
Conversion of preferred stock into common stock (in shares)						50,000
Foreign currency translation adjustment																	37,873									37,873
Warrant modification															49,160											49,160
Deemed dividend on down round feature															405,324				(405,324)							0
Net loss																			(5,324,580)							(5,324,580)
Balance at Dec. 31, 2018																			(76,890)	$ 6,679,585						6,602,695
Investment by non-controlling interest																				1,400,000						1,400,000
Net Loss																			(1,859,069)							(1,859,069)
Balance at Sep. 30, 2019																			(1,935,959)	8,079,585						6,143,626
Balance at Sep. 30, 2019					$ 5,253,734				$ 1,717						49,088,693		42,894		(50,464,920)							3,922,118
Balance (in shares) at Sep. 30, 2019					710,869				17,163,400
Balance at Jun. 30, 2019					$ 5,268,734				$ 1,521						45,249,263		10,218		(48,649,236)							1,880,500
Balance (in shares) at Jun. 30, 2019					710,869				15,207,956
Issuance of registered common shares, net of offering costs			$ (15,000)						$ 188						3,035,369									(15,000)		3,035,557
Issuance of registered common shares, net of offering costs (in shares)									1,877,666
Issuance of preferred stock			$ (15,000)						$ 188						3,035,369									$ (15,000)		3,035,557
Issuance of preferred stock (in shares)									1,877,666
Preferred Stock Conversion						$ 5				$ 89,995											$ 90,000
Preferred stock dividends									$ 3						49,997				(103,887)							(53,887)
Preferred stock dividends (in shares)									27,778
Preferred Stock Conversion (in shares)						50,000
Share-based employee and director compensation															209,585											209,585
Conversion of debt into common stock (in shares)						50,000
Foreign currency translation adjustment																	32,676									32,676
Warrant modification															49,160											49,160
Deemed dividend on down round feature															405,324				(405,324)
Net loss																			(1,306,473)							(1,306,473)
Balance at Jun. 30, 2019																			(1,207,622)	8,079,585						6,871,963
Net Loss																			(728,337)							(728,337)
Balance at Sep. 30, 2019																			(1,935,959)	$ 8,079,585						6,143,626
Balance at Sep. 30, 2019					$ 5,253,734				$ 1,717						$ 49,088,693		$ 42,894		$ (50,464,920)							$ 3,922,118
Balance (in shares) at Sep. 30, 2019					710,869				17,163,400

Basis of Presentation and Going

Basis of Presentation and Going Concern	9 Months Ended
	Sep. 30, 2019
Basis Of Presentation And Going Concern
Basis of Presentation and Going Concern	Note 1. Basis of Presentation and Going Concern Nature of Operations - BioHiTech Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned and its controlled subsidiaries offers cost-effective and technologically innovative advancements integrating technological, biological and mechanical engineering solutions for the control, reduction and / or reuse of organic and municipal waste. As of September 30, 2019 and December 31, 2018, the Company’s active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC, and its controlled subsidiary was Refuel America LLC (60%) and its wholly-owned subsidiaries Apple Valley Waste Technologies Buyer, Inc., Apple Valley Waste Technologies, LLC, New Windsor Resource Recovery LLC and Rensselaer Resource Recovery LLC and its controlled subsidiary Entsorga West Virginia LLC (88.7% as of September 30, 2019). As of September 30, 2018, the Company’s active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC, and New Windsor Resource Recovery LLC. Basis of Presentation - The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned and controlled subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10‑Q and Article 8 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management’s opinion, however, that the accompanying condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31, 2018, which contains the audited financial statements and notes thereto, for the years ended December 31, 2018 and 2017 included within the Company’s Form 10‑K filed with the Securities and Exchange Commission (“SEC”) on April 1, 2019. The financial information as of December 31, 2018 presented hereto is derived from the audited consolidated financial statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2018. The interim results for the three and nine months ended September 30, 2019 is not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for any future interim periods. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern and Liquidity - For the nine months September 30, 2019, the Company had a consolidated net loss of $7,183,649, incurred a consolidated loss from operations of $5,462,215 and used net cash in consolidated operating activities of $6,017,512. At September 30, 2019, consolidated total stockholders’ equity amounted to $10,065,744, consolidated stockholders’ equity attributable to parent amounted to $3,922,118 and the Company had a consolidated working capital deficit of $2,362,974. The Company does not yet have a history of financial profitability. Historically, the principal source of liquidity has been the issuance of debt and equity securities. Presently, the Company does not have firm commitments to fund its future operational and strategic plans. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management’s further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through equity and/or debt raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification. The Company is presently in the process of raising additional debt for general operations and to support its leasing activities. The Company may also raise capital through its Registration Statement on Form S-3 declared effective on July 11, 2018, by the Securities and Exchange Commission (the "Shelf Registration") for investment in several strategic initiatives. The Shelf Registration was utilized during September 2019 to raise net proceeds of $3,035,557 through a confidentially marketed public offering of common shares. There is no assurance that the Company will be able to raise sufficient capital or debt to sustain operations or to pursue other strategic initiatives or that such financing will be on terms that are favorable to the Company.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, valuation of deferred tax assets, share based compensation, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including intangibles, and useful lives and other provisions and contingencies. Foreign Operations — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables. Product and Services Revenue Recognition — The Company records revenue based on a five-step model in accordance with ASC 606, Revenue from Contracts with Customers, which require that we: 1. Identify the contract with a customer; 2. Identify the performance obligations in the contract; 3. Determine the transaction price of the contract; 4. Allocate the transaction price to the performance obligations in the contract; 5. Recognize revenue when the performance obligations are met or delivered. When revenue is earned based on product sales, such as sales of digester equipment and parts, solid recovered fuel and recycled materials, the Company’s performance obligations are satisfied at the point in time when products are shipped to the customer, which is when the customer has title and control. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of products. When revenue is earned based on receipt of disposal waste, the Company's performance obligations are satisfied at the point in time when disposal waste products are received from the customer, which is when the Company has title and control. Therefore, the Company's contracts have a single performance obligation (receipt of disposal waste). When revenue is earned on services, such as management advisory fees and digester maintenance and repair services fees are recognized over the period the services are performed based on service milestones. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. Lease Revenue Recognition — Rental, service and maintenance revenues relating to the Company’s rental agreements involve providing use of the Company’s digesters at customer locations, access to our software as a service and preventative maintenance over the term. The agreements generally provide for flat monthly payments that the Company believes are consistent with our costs and obligations underlying the agreements. The Company selected the practical expedient not to separate non-lease components from lease components. The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: · The lease transfers ownership of the underlying asset to the lessee by the end of the lease term, · The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise, · The Lease term is for the major part of the remaining economic life of the underlying asset. However, if the commencement date falls at or near the end of the economic life of the underlying asset, this criterion shall not be used for purposes of classifying the lease, · The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset or · The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. Restricted Cash — Includes Restricted cash that is restricted as to its use, as it is held by a trustee in accordance with the West Virginia Economic Development Authority bond agreement. These amounts are held by the Company’s trustee in various bank accounts segregated for specific uses related to the construction and operation of the resource recovery facility. Amounts required to meet current operations of the Company have been classified as current in the accompanying consolidated balance sheets. HEBioT Facility — High Efficiency Biological Treatment (“HEBioT”) facility was under construction through March 31, 2019 and includes all costs incurred to bring an asset to the condition and location necessary for its intended use, with some continuing finalizations and adjustments. Included in the capitalized costs are construction, legal, leasehold improvements, and interest. Since April 1, 2019, these costs have been depreciated based on estimated lives ranging from 10 to 35 years. MBT Facility Development Costs — The Company defers costs relating to on-going Mechanical Biological Treatment (“MBT”) facility development costs commencing upon the Company’s determination that the project will be completed. These site specific costs generally include external costs generally relating to legal, engineering and other costs relating to the acquisitions of land, permits and licenses. Upon commencement of construction, to the extent that costs relate to the facility, they are transferred to the construction in progress. Investments in Unconsolidated Entities —The Company has utilized the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. In circumstances where the Company does not have the ability to exercise significant influence or control over the operating and financial policies of the investee, the investment is carried at cost, less impairment, adjusted for subsequent changes to estimated fair value up to the original cost. As of September 30, 2019, the Company had no investments in unconsolidated investments as a result of its July 3, 3019 sale of its investment in Gold Medal Group, LLC ("GMG"), which was comprised of 2,250,000 GMG Investment Preferred Units and 2,250,000 Class A Common Units, to Gold Medal Equity, LLC ("GME"), the parent entity to GMG for total compensation of $2,250,000. As of July 3, 2019 these investments were carried by the Company with an adjusted cost of $1,687,383 resulting in a gain of $562,617 on July 3, 2019, which was recorded as gain on sale of affiliate investment in the accompanying condensed consolidated statements of operations and comprehensive loss. Deferred Financing Costs — Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments. Income Taxes — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. During the three months ended September 30, 2019, the Company incurred a cumulative change in ownership of greater than 50% under Internal Revenue Code Section 382. The effect of this cumulative change in ownership will greatly reduce the availability of net operating loss carryforwards. As of December 31, 2018 and at the time of the cumulative change, all of the Company’s deferred tax assets related to the availability of net operating loss carryforwards had been reserved 100%. Loss per Share — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” Dividends attributable to preferred stock, whether declared or accrued, and deemed dividends on down round feature are deducted from income attributable to common shareholders for purposes of earnings per share. The Company’s potential dilutive instruments include convertible preferred stock, options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Acquisition and Contribution Ag

Acquisition and Contribution Agreement	9 Months Ended
	Sep. 30, 2019
Acquisition and Contribution Agreement
Acquisition and Contribution Agreement	Note 3. Acquisition and Contribution Agreement On November 28, 2018, Company entered into a definitive agreement (the “MIPS”) with Entsorga USA, Inc. (“EUSA”) whereby EUSA agreed to sell, transfer and convey to BioHiTech 2,687 membership units of Entsorga West Virginia, LLC (“EWV”) (the “Membership units”) in consideration of 714,519 shares of BioHiTech’s newly created Series E convertible preferred stock (the “Sr. E CPS). At the time, EWV was a facility under construction that is intended to utilize HEBioT technology to divert municipal solid waste from landfills and to create an EPA recognized alternative commodity fuel, which has since commenced operations. On December 14, 2018, the EUSA transaction was consummated. The 714,519 shares of Sr. E CPS were valued at $1,886,630 based on the underlying common shares which the Sr. E CPS is convertible into. The total acquisition price of $2,863,583 is comprised of the aforementioned transaction, plus $976,953 of previously held equity in EWV. Upon consummation of the MIPS agreement BioHiTech owned a total of 4,410.4 membership units of EWV, comprised of the 2,687 units resulting from the MIPS agreement and 1,723.4 units previously acquired by BioHiTech during 2017. The 4,410.4 membership units represented 44.1% of the total membership units issued by EWV, which combined with BioHiTech’s control of EWV’s board, management and having the largest ownership block of EUSA, with the next largest block, which represents 34.1%, an entity over which BioHiTech has controlling financial interest, results in the investment being recognized in the Company’s financial statements on a consolidated basis. Following the consummation of the MIPS, on December 14, 2018, BioHiTech entered into a Contribution and Transaction Agreement (“CTA”) with Gold Medal Group, LLC (“GMG”) and a newly formed subsidiary Refuel America, LLC (“Refuel”) of the Company whereby GMG contributed $3,500,000 in cash and its 34.1% ownership interest in EVW (owned by GMG’s wholly owned subsidiary Apple Valley Waste Technologies, LLC) into Refuel and BioHiTech contributed it’s 44.1% interest in EWV, a technology license for a future HEBioT facility that BioHiTech carried at a value of $6,019,200 and $316,207 in capitalized costs relating to two separate HEBioT facility on-going projects. In exchange for the assets contributed, BioHiTech and GMG acquired 60% and 40%, respectively, of the membership units of Refuel, which approximate the carrying value of each of the BioHiTech and GMG assets contributed. As a result of there being a continuation in proportional ownership of the significant assets and the affiliate nature BioHiTech and GMG through a non-controlling interest of GMG being owned by BioHiTech and there being a management agreement between GMG’s largest subsidiary, Gold Medal Holdings, LLC (“GMH”) whereby BioHiTech provides executive management of GMH with control over the strategic and operational activities of GMH, the CTA transaction has been accounted for without separate acquisition accounting applied to the CTA elements. The following presents unaudited pro forma information as if the acquisition had occurred as of January 1, 2018. The pro forma results do not include any anticipated cost synergies or other effects of the integration of the acquired company. Pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the dates indicated, nor is it indicative of future operating results of the combined company. For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Pro forma revenue $ 1,426,775 $ 1,088,082 $ 3,212,689 $ 2,642,946 Pro forma net loss (1,306,473) (2,243,309) (7,183,649) (13,310,199) Proforma earnings per share – basic and diluted (0.13) (0.16) (0.41) (1.02)

Accounts Receivable, net

Accounts Receivable, net	9 Months Ended
	Sep. 30, 2019
Accounts Receivable, net
Accounts Receivable, net	Note 4. Accounts Receivable, net Accounts receivable consists of the following: September 30, December 31, 2019 2018 Accounts receivable $ 1,675,040 $ 513,336 Less: allowance for doubtful accounts receivable (155,039) (110,038) $ 1,520,001 $ 403,298

Inventory

Inventory	9 Months Ended
	Sep. 30, 2019
Inventory
Inventory	Note 5. Inventory Inventory, comprised of finished goods and parts or assemblies, consist of the following: September 30, December 31, 2019 2018 Equipment $ 156,419 $ 169,540 Parts and assemblies 272,779 330,308 $ 429,198 $ 499,848

Equipment on Operating Leases,

Equipment on Operating Leases, net	9 Months Ended
	Sep. 30, 2019
Equipment on Operating leases
Equipment on Operating Leases, net	Note 6. Equipment on Operating Leases, net Equipment on operating leases consist of the following: September 30, December 31, 2019 2018 Leased equipment $ 3,117,960 $ 3,054,097 Less: accumulated depreciation (1,440,846) (1,305,210) $ 1,677,114 $ 1,748,887 During the three months ended September 30, 2019 and 2018, depreciation expense on leased equipment amounted to $110,795 and $94,967, respectively. During the nine months ended September 30, 2019 and 2018, depreciation expense on leased equipment amounted to $316,061 and $267,229, respectively. The Company is a lessor of digester units under non-cancellable operating lease agreements expiring through May 2025. These leases generally have terms of three to five years and do not contain stated extension periods or options for the lessee to purchase the underlying assets. At the end of the leases, the lessee may enter into a new lease or return the asset, which would be available to the Company for releasing. During the three months ended September 30, 2019 and 2018, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $369,437 and $299,537, respectively. During the nine months ended September 30, 2019 and 2018, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $1,061,289 and $852,675, respectively. The minimum future estimated contractual payments to be received under these leases as of September 30, 2019 is as follows: Year ending December 31, 2019 (remaining) $ 382,069 2020 1,259,264 2021 920,137 2022 644,860 2023 and thereafter 468,856 Total minimum future lease income as of September 30, 2019 $ 3,675,186

HEBioT Facility

HEBioT Facility	9 Months Ended
	Sep. 30, 2019
HEBioT Facility.
HEBioT Facility	Note 7. HEBioT Facility The Company’s HEBioT facility in Martinsburg, West Virginia accepted its first test loads of solid municipal waste on March 29, 2019 to commence commissioning and equipment calibration. The Company capitalizes all costs incurred to bring an asset to the condition and location necessary for its intended use. Included in the capitalized costs are construction, specialized equipment, legal, leasehold improvements, and interest. Capitalized interest relates to the State of West Virginia Revenue Bonds and amounted to $618,706 for the three months ended March 31, 2019. The facility, while continuing commissioning and some continuing construction, was placed in service on April 1, 2019. Depreciation expense amounted to $458,968 for the three months ended September 30, 2019 and to $917,937 for the nine months ended September 30, 2019 based on estimated lives ranging from 10 to 35 years.

MBT Facility Development and Li

MBT Facility Development and License Costs	9 Months Ended
	Sep. 30, 2019
MBT Facility Development and License Costs
MBT Facility Development and License Costs	Note 8. MBT Facility Development and License Costs MBT Facility Development and License Costs consist of the following: September 30, December 31, 2019 2018 MBT Projects New Windsor, New York: Land acquisition $ — $ 66,000 Legal — 46,030 Survey and engineering — 300,624 — 412,654 Rensselaer, New York: Survey and engineering 212,567 153,554 Total MBT projects 212,567 566,208 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $63,000 of amortization as of September 30, 2019 1,827,000 1,890,000 Total Technology Licenses 7,846,200 7,909,200 Total MBT Facility Development and License Costs $ 8,058,767 $ 8,475,408 MBT Facility Development Costs New Windsor, New York As of December 31, 2018, the Company was pursuing local and state permits, and other approvals required to continue development of the project. During the three months ended March 31, 2019, the Company elected to rescind an agreement for the purchase of real property with the Town of New Windsor in exchange for a return of the $66,000 paid by the Company under the rescinded contract and to relocate the project. While the Company is presently investigating several other sites for the project, as a result of abandoning the initial site, the Company has reflected an impairment expense of $346,654 relating to the site during the nine months ended September 30, 2019 in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations and comprehensive loss. Rensselaer, New York During 2018, the Company commenced initial development of a project in Rensselaer, NY. As of September 30, 2019, the Company has received local permits and has filed the required state permit applications, which are undergoing review by the New York State Department of Environmental Conservation. HEBioT Technology Licenses Technology License Agreement – Future Facility On November 1, 2017, the Company entered into a Technology License Agreement (the “License Agreement”) with Entsorgafin S.p.A. (“Entsorga”) whereby the Company acquired a license for the design, development construction, installation and operation of a High Efficiency Biological Treatment (“HEBioT”) renewable waste facility with a capacity of 165,000 tons per year. The patented HEBioT technology converts mixed municipal and organic waste to a US Environmental Protection Agency recognized alternative fuel source. The royalty payment for the license amounted to $6,019,200. This Technology License Agreement can be utilized at a future project and will be amortized once the facility is in operation. Technology License Agreement – Martinsburg, West Virginia In connection with the acquisition accounting applied to Entsorga West Virginia acquisition consummated on December 14, 2018, the facility License Agreement was valued at $1,890,000. During the three and nine months ending September 30, 2019 amortization expense amounted to $31,500 and $63,000, respectively , based on an estimated fifteen year life.

Risk Concentrations

Risk Concentrations	9 Months Ended
	Sep. 30, 2019
Risk Concentrations
Risk Concentrations	Note 9. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2019: Revenue, for the nine months ended September 30, 2019 $ 2,877,157 $ 335,532 $ 3,212,689 Revenue, for the three months ended September 30, 2019 1,333,878 92,897 1,426,775 Non-current tangible assets, as of September 30, 2019 40,802,758 259,449 41,062,207 2018: Revenue, for the nine months ended September 30, 2018 $ 2,333,242 $ 309,704 $ 2,642,946 Revenue, for the three months ended September 30, 2018 939,503 148,579 1,088,082 Non-current tangible assets, as of December 31, 2018 34,630,978 284,444 34,915,422 Credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and the Financial Conduct Authority (“FCA”) in the UK insurance limits. Through September 30, 2019, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Major customers — During the three months ended September 30, 2019, one customer represented at least 10% of revenues, accounting for 58.9% (Gold Medal Group, LLC, an affiliated entity, “GMG”) of revenues. During the three months ended September 30, 2018, two customers represented at least 10% of revenues, accounting for 31.3% (GMG) and 10.1% of revenues. During the nine months ended September 30, 2019, one customer represented at least 10% of revenues, 49.2% (GMG) of revenues. During the nine months ended September 30, 2018, one customer represented at least 10% of revenues, 38.0% (GMG) of revenues. As of September 30, 2019, one customer represented at least 10% of accounts receivable, accounting for 59.6% (GMG) of accounts receivable. As of December 31, 2018, one customer represented at least 10% of accounts receivable, accounting for 32.8% (GMG) of accounts receivable. Vendor concentration — During the three months ended September 30, 2019, two vendors represented at least 10% of costs of revenue, accounting for 21.5% (GMG) and 16.3% (a 1.2% shareholder). During the nine months ended September 30, 2019, two vendors represented at least 10% of costs of revenue, accounting for 11.9% (GMG) and 16.3% (a 1.2% shareholder). During the three months ended September 30, 2018, one vendor represented at least 10% of costs of revenue, accounting for 18.9% (a 1.2% shareholder). During the nine months ended September 30, 2018, two vendors represented at least 10% of costs of revenue, accounting for 28.7% (a 1.2% shareholder) and 12.1%. As of September 30, 2019, excluding construction payables and other professional fees, one vendor represented at least 10% of accounts payable accounting for 37.2% (GMG) of accounts payable. As of December 31, 2018, one vendor represented at least 10% of accounts payable, accounting for 12.0% (a 1.4% shareholder) of accounts payable. Affiliate relationship — GMG owns a 40% interest in Refuel America, LLC, a consolidated subsidiary of the Company. GMG’s subsidiaries, which are not consolidated in the Company’s financial statements have several business relationships with the Company and its subsidiaries that result in revenues and expenses noted above. See Note 16. Related Party Transactions.

Line of Credit, Notes Payable,

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt	9 Months Ended
	Sep. 30, 2019
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt	Note 10. Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt Notes, lines, advances and long-term debts are comprised of the following: September 30, 2019 December 31, 2018 Related Related Total Party Total Party Line of credit $ 1,478,340 $ — $ 1,469,330 $ — Senior secured promissory note 4,080,947 — 3,851,305 — Junior promissory note 942,214 942,214 926,211 926,211 Note payable 100,000 — 100,000 — Advance from related party 210,000 210,000 — — Long term debt - current and long-term portion 15,125 — 21,971 — Line of Credit — On February 2, 2018, the Company’s subsidiary, BHT Financial, LLC (“BHTF”) entered into a new Credit Agreement (the “Credit Agreement”) and a Master Revolving Note (the “Note”) with Comerica that provides for a facility of up to $1,000,000, secured by the assets of BHTF. The Credit Agreement and Note were amended on November 9, 2018 to increase the facility to $1,500,000. The Note does not have any financial covenants, carries interest at the rate of 3%, plus either the Comerica prime rate or a LIBOR-based rate, (5.68% and 6.52% as of September 30, 2019 and December 31, 2018, respectively) and matures on January 1, 2020. The line of credit is secured by the assets of BHTF and is personally guaranteed by the Company’s Chief Executive Officer, Frank E. Celli and James C. Chambers, a director. As of September 30, 2019, the $1,500,000 balance outstanding is presented net of $30,445 in issuance costs associated with the financing, net of $8,785 in amortization. As December 31, 2018, the $1,500,000 balance outstanding is presented net of $34,945 in issuance costs associated with the financing, net of $4,275 in amortization, respectively, calculated on the effective interest method, which is included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. Michaelson Senior Secured Term Promissory Financing – On February 2, 2018, the Company and several of the Company’s wholly-owned subsidiaries entered into and consummated a Note Purchase and Security Agreement (the “Purchase Agreement”) with Michaelson Capital Special Finance Fund II, L.P. (“ MCSFF ”) to issue a senior secured term promissory note in the principal amount of $5,000,000 (the “Note”). The Note is not convertible and accrues interest at the rate of 10.25% per annum. The Note provides for certain financial covenants that were not met as of September 30, 2019 and December 31, 2018 and a waiver of such was granted by MCSFF. The Note is to be repaid in eight, equal, quarterly installments of $625,000 commencing on May 15, 2021 and ending February 2, 2023 (the “Maturity Date”). Additionally, the Note is secured by a general security interest in all of the Company’s assets as well all of the assets of the Company’s subsidiaries, excluding those of Entsorga West Virginia LLC which is subject to superior security interests relating to the Entsorga West Virginia LLC WVEDA bonds. Further, the Company’s Chief Executive Officer, guaranteed a portion of the Registrant’s obligations to MCSFF. In connection with the issuance of the Note, the Company issued MCSFF 320,000 shares of the Registrant’s common stock, par value $0.0001 per share. As of September 30, 2019 and December 31, 2018, the carrying balance of the Note is comprised of $5,000,000 face value, less $1,212,121 allocated to the common stock issued based upon the market value on the date issued, less associated amortization of $418,363 and $223,443, respectively, on the stock discount, less deferred financing costs of $211,187, less $85,892 and $51,170, respectively, of associated deferred financing cost amortization. All amortization is computed on the effective interest method and included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. Junior Promissory Note – On February 2, 2018, the Company entered into a Securities Exchange and Note Purchase Agreement (the “Exchange Agreement”) with Frank E. Celli, the Company’s Chief Executive Officer, whereby Celli exchanged $4,500,000 in a note receivable from the Company and $544,777 in advances made to the Company for $4,000,000 of the Registrant’s Series C Convertible Preferred Stock, par value $0.0001 (the “Series C Preferred Stock”) and a junior promissory note (the “Junior Note”) amounting to $1,044,477, which is carried net of discounts amounting to $135,823, less associated amortization of $33,560 and $17,557 as of September 30, 2019 and December 31, 2018, respectively. The Junior Note, which is subordinated to the senior secured note, is not convertible, accrues interest at the rate of 10.25% per annum and matures on February 2, 2024. Note Payable — As of September 30, 2019 and December 31, 2018, the note, with interest at 10%, had a remaining balance outstanding of $100,000 and matures on January 1, 2020. Long Term Debt — Represents two loans collateralized by vehicles with interest ranging from 1.9% to 4.99%, each with amortizing principal payment requirements through 2020 and 2022, respectively. Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — as of September 30, 2019, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2019 (remaining) $ 2,319 $ — $ 2,319 2020 4,605 100,000 104,605 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 and thereafter — 1,669,477 1,669,477 Total $ 15,125 $ 6,144,477 $ 6,159,602

Entsorga West Virginia, LLC WVE

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	9 Months Ended
	Sep. 30, 2019
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	Note 11. Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds During 2016, Entsorga West Virginia LLC (the “Borrower”) was issued $25,000,000 in Solid Waste Revenue Bonds from the West Virginia Economic Development Authority (the “WVEDA Bonds”). The WVEDA Bonds were issued in two series with one for $7,535,000 bearing interest at 6.75% per annum with a maturity date of February 1, 2026 and the second for $17,465,000 bearing interest at 7.25% per annum with a maturity of February 1, 2036. Both series were issued at par. The 2026 series was payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. The 2036 series is payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. Repayment of principal is by way of sinking fund. During 2018, the 2016 Indenture Trust and Loan Agreement were amended and restated effective November 1, 2018. These amendments provided for a third series of bonds amounting to $8,000,000 bearing interest at 8.75% per annum with a maturity date of February 1, 2036, with special event triggered pre-payment requirements. This series was issued at par. The 2036 series is payable with interest-only payments through February 1, 2020 then annual payments of principal and semi-annual payments of interest through maturity. Repayment is by way of sinking fund. The outstanding balance of the WVEDA Bonds as of September 30, 2019 and December 31, 2018 is $33,000,000, which is presented net of unamortized debt issuance costs amounting to $2,207,759 and $2,145,608, less associated amortization of $315,136 and $231,510, respectively, which includes amortization prior to the Company’s control acquisition in 2018. The loan agreement and indenture of trust place restrictions on the Borrower and its members regarding additional encumbrances on the property, disposition of the property, and limitations on equity distributions. The loan agreement also provides for financial covenants, which became effective on September 30, 2019. As of September 30, 2019 the Company was not in compliance with all of the financial covenants and has entered into a forbearance agreement with the bond trustee that provides they will not accelerate the repayment of the bonds due to the financial covenant default through October 1, 2020. The future sinking fund payments by the Borrower as of September 30, 2019 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2019 (remaining) $ — $ — $ — $ — 2020 1,160,000 — 230,000 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 and thereafter 4,260,000 17,465,000 7,240,000 28,965,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000 In connection with the November 1, 2018 amendment and restatement of the WVEDA Bonds, Comerica Bank issued a standby letter of credit in the amount of $1,250,000 (the “SbyLoC”) for the benefit of the WVEDA Bond trustee that is collateralized by the Company’s cash. The SbyLoC expires on December 31, 2019 and is drawable should the Company have an unfavorable result in the complaint file by Lemartec Corporation further disclosed in Note 14.

Equity and Equity Transactions

Equity and Equity Transactions	9 Months Ended
	Sep. 30, 2019
Equity and Equity Transactions
Equity and Equity Transactions	Note 12. Equity and Equity Transactions The Company has 50,000,000 shares of its $0.0001 par common stock and 10,000,000 shares of blank check preferred stock authorized by its shareholders. As of September 30, 2019 and December 31, 2018, 17,163,400 and 14,802,956 shares of common stock have been issued; and 3,179,120 and 3,159,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,018,375 in accumulated, but undeclared preferential dividends as of September 30, 2019, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value September 30, 2019 December 31, 2018 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 163,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 18,850 — Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 564,519 Under the terms of the Company’s senior lender agreements, the Company is restricted from paying dividends in cash, but is allowed to pay dividends in common stock. The Company, since its merger in 2015, has not paid any cash or stock dividends on common stock. The consolidated financial statements include less than 100% owned and controlled subsidiaries and include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries. Entsorga West Virginia LLC through its limited liability agreement and the agreements related to its WVEDA Bonds have restrictions on distributions to and loans to owners while the WVEDA Bonds are outstanding. On September 9, 2019 the Company issued 1,877,666 registered shares of its $0.0001 par common stock through its Registration Statement on Form S-3 declared effective on July 11, 2018, by the Securities and Exchange Commission. The shares were offered through a confidentially marketed public offering and were sold at a per share price of $1.80 per share. The gross proceeds of the offering amounted to $3,379,799, which net of placement fees of $195,461, legal fees of $135,359, regulatory filing fees of $8,000 and $5,422 of other costs resulted in net proceeds to the Company of $3,035,557. In connection with the placement agent fees, the Company issued warrants for 56,330 shares, exercisable between March 11, 2020 and September 10, 2019 at an exercise price of $2.25 per warrant share. On September 9, 2019 the holder of Series A Preferred stock converted 18,000 shares of Series A preferred stock for 50,000 shares of the Company’s $0.0001 par common stock. On September 26, 2019 the Company paid $50,000 of Series A preferred stock accrued dividend through the issuance of 27,778 shares of the Company’s $0.0001 par common stock. Series D Convertible Preferred Stock – On February 11, 2019 the Company filed a Certificate of Designation for 20,000 shares of Series D Convertible Preferred Stock that was amended on May 1, 2019 (“Sr. D CPS”). The Sr. D CPS is convertible into shares of the Company’s common stock at the price of $3.50 per share based on the Sr. D CPS’s stated value being converted. Each share of the Sr. D CPS has a stated value of $100 and has dividends at the rate of 9% payable annually in arrears in cash or at the Company’s option, in common stock based upon the then in effect conversion price. The Sr. D CPS also has an alternative dividend provision based upon the cash flow distributed to the parent from the Company’s next HEBioT facility, excluding the plant in Martinsburg, West Virginia, (the “Next Facility”) based upon the Sr. D CPS proportional investment in the facility. The Sr. D CPS also has an alternative conversion based upon a multiple the annualized EBITDA of the Next Facility converted at the higher of the conversion rate in effect or the market price of the Company’s common stock if higher. The Company received subscriptions and investments totaling $1,885,000 through June 20, 2019, which were issued 18,850 shares of Sr D CPS. In addition to the Sr. D CPS, each holder received warrants to acquire 50% of the shares that the Sr. D CPS is convertible into with an exercise price of $3.50 per share and an expiration on the fifth year anniversary. A total of 269,296 five-year warrants with an exercise price of $3.50 were issued to the Sr. D CPS holders that were valued utilizing the Black-Scholes modelling technique utilizing stock prices ranging from $1.88 to $2.70, a standard deviation (volatility) ranging from 44.55% to 46.38% and a risk-free rate interest rate ranging from 1.74% to 2.56% based on the date of the investment. The model includes subjective input assumptions that can materially affect the fair value estimates. The allocated fair value of the warrants amounting to $190,299 has been reflected in additional paid in capital. In connection with the offering and issuance of the Sr D CPS, the holder of the Series A convertible preferred stock was issued 116,651 warrants in the form issued to the Sr D CPS holders. These warrants, which were reflected as a cost of issuing the Sr D CPS, were valued utilizing the Black-Scholes modelling technique utilizing a stock price of $2.25, a standard deviation (volatility) of 46.23% and a risk-free interest rate of 1.89% on the date of issuance. Warrants – In connection with the issuance of convertible debt, preferred and common stock and in connection with services provided, the Company has the 4,674,261 warrants to acquire the Company’s common stock outstanding as of September 30, 2019, as follows: Weighted Expiring During the Year Exercise Price Average Price Ending December 31, Warrant Shares per Share per Share 2020 22,860 $3.50 $3.50 2021 1,768,516 $1.80 to $3.30 $3.25 2022 1,699,861 $1.80 to $5.00 $2.60 2023 740,749 $1.80 $1.80 2024 385,945 $1.80 $1.80 2025 56,330 $2.25 $2.25 The following table summarizes the outstanding warrant activity through September 30, 2019: Outstanding, January 1, 2019 4,201,736 Issued 442,275 Issued as a result of common stock offering at $1.80 per share 30,250 Exercised — Expired — Outstanding, September 30, 2019 4,674,261 In connection with the confidentially marketed public offering that closed on September 9, 2019 at a price per common share of $1.80, 70 warrants representing the right to acquire 1,992,325 shares with down-deal exercise price features were re-priced to an exercise price of $1.80. In connection with the modification the value of the warrants was recalculated based upon the value immediately prior to the modification and immediately after the modification. In connection therewith the Company utilized Black Scholes valuation models utilizing volatility of 50.56% and a risk free rate of 1.51% together with the contractual remaining terms of each warrant. This revaluation increased the value of the warrants by $405,324, which has been reflected as an increase in accumulated deficit and additional paid in capital. In accordance with Accounting Standards Update No. 2017-11, this increased valuation is not charged to the consolidated statement of operations and comprehensive loss however, it is included as an adjustment to net loss attributable to parent in arriving at net loss per common share – basic and diluted. Also in connection with the confidentially marketed public offering that closed on September 9, 2019, the holder of the Series A preferred stock had the option to require that the Company redeem shares of Series A preferred stock up to an amount representing 50% of the offering. In connection therewith, the holder agreed to not require the redemption in exchange for an extension of one year to the warrants originally issued in connection with the Series A preferred stock; all other contractual terms of the Series A preferred stock remained unchanged. Utilizing the same Black Scholes valuation model variables as utilized in connection with the down deal, above, the change in valuation amounted to $49,160. As the redemption features remained unchanged, the Series A preferred stock continues to be accounted for as temporary equity, which require that the modification be charged to the consolidated statement of operations and comprehensive loss.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2019
Equity Incentive Plans
Equity Incentive Plans	Note 13. Equity Incentive Plans The Company has two equity incentive plans: 2015 Equity Incentive Plan — During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. 2017 Executive Incentive Plan — During 2017, the shareholders approved the 2017 Executive Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 1,000,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. Compensation expense related to stock options and restricted stock was: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Stock options $ 31,323 $ 68,264 $ 104,075 $ 115,530 Restricted stock 178,262 262,064 637,113 369,714 Total $ 209,585 $ 330,328 $ 741,188 $ 485,244 Compensation expense related to stock options and restricted stock was reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Rental, service and maintenance $ 3,353 $ 8,406 $ 12,426 $ 17,075 Selling, general and administrative 206,232 321,922 728,762 468,169 Total $ 209,585 $ 330,328 $ 741,188 $ 485,244 There were no grants of options or restricted stock during the three and nine months ended September 30, 2019. Unvested restricted stock activity was: Balance, January 1, 2019 742,741 Grants — Forfeited (40,120) Vested (295,053) Balance, September 30, 2019 407,568

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies
Commitments and Contingencies	Note 14. Commitments and Contingencies From time to time, the Company is involved in legal matters arising in the ordinary course of business, during the nine months ended September 30, 2019 the Company was involved in the following matters. The Company had accrued their contractual obligations but disputed payment for a consulting services agreement with Tusk Ventures LLC (“Tusk”), in which Tusk claim that it is owed $250,000 pursuant to an agreement. This matter was filed in the Supreme Court of the State of New York, New York County in April 2017. This matter was settled on April 23, 2019. In connection with the settlement, the Company issued to the plaintiff 75,000 shares of its common stock. On February 7, 2018, Lemartec Corporation (“Lemartec”) filed a complaint against the Company in the United States District Court for the Northern District of West Virginia arising out of the construction of the Company’s resource recovery facility in Martinsburg, West Virginia alleging breach of contract and unjust enrichment. The Company has filed its answer and counterclaims for damages against Lemartec and cross claims against Lemartec’s performance bond surety, Philadelphia Indemnity Insurance Company. Trial is expected to begin in August 2020 and the Company intends to vigorously defend the complaint. It is management’s opinion that the resolution of these known claims will not materially effect the Company’s financial position, results of operations, or cash flows. There can be no assurance, however, that unforeseen circumstances will not result in significant costs. While the Company believes that these such matters are currently not a risk material to the Company’s financial position, there can be no assurance that these or other matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases
Leases	Note 15. Leases Effective January 1, 2019, the Company implemented Accounting Standards Codification 842, Leases. The guidance requires lessees to recognize most leases on the balance sheet but does not change the manner in which expenses are recorded in the income statement. The two permitted transition methods under the guidance are the modified retrospective transition approach, which requires application of the guidance for all comparative periods presented, and the cumulative effect adjustment approach, which requires prospective application at the adoption date. The Company utilized the optional transition method to assess the impact of this guidance on the Company’s financial statements and related disclosures, including the increase in the assets and liabilities on our balance sheet from lessee perspective. The Company completed a comprehensive review of its leases that were impacted by the new guidance. As part of the adoption, the Company elected the ‘package of practical expedients,’ which permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs, therefore the Company did not restate prior comparative periods. The Company rents its headquarters and attached warehousing space from a related party (see Note 16) and has a land lease relating to the Martinsburg, WV HEBioT facility under operating leases. The HEBioT facility land lease has an initial term of 30 years, plus four 5‑year extensions. For purposes of our determination of lease liabilities, extensions were not included. As the leases do not provide an implicit rate, the Company used incremental borrowing rates in determining the present value of lease payments. For the HEBioT facility land lease a rate of 11% was utilized and a rate of 10.25% was used on the other leases. The current portion of the lease liabilities of $169,575 is included in accrued expenses and liabilities. Total lease costs under operating leases amounted to $55,356 and $37,874 for the three months, and $166,067 and $108,182 for the nine months ended September 30, 2019 and 2018, respectively. Maturities of lease liabilities under these leases, which have a weighted average remaining term of 25.1 years, as of September 30, 2019 is: Year Ending December 31, 2019 (remaining) $ 51,406 2020 146,926 2021 109,000 2022 113,000 2023 and thereafter 3,093,750 Total lease payments 3,514,082 Less imputed interest (2,431,140) Present value of lease liabilities $ 1,082,942 During the nine months ended September 30, 2019, the Company recognized operating lease right of use assets in exchange for lease liabilities amounting to $1,045,755 and had operating cash flows for operating leases amounting to $51,406 and $143,597 for the three and nine months ended September 30, 2019, respectively.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions
Related Party Transactions	Note 16. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a transaction. Related parties also include GMG and its subsidiaries. As of September 30, 2019, GMG is controlled by several private equity funds managed by Kinderhook Industries. The Company initially invested in GMG on January 25, 2018. On July 3, 2019 the Company sold its ownership interests in GMG to an entity controlled by Kinderhook Industries. As discussed in Note 3, on December 14, 2018 the Company formed a new consolidated subsidiary, Refuel America, LLC (“Refuel”) into which the Company contributed specified assets, including its ownership interest in Entsorga West Virginia, LLC (“EWV”) and other HEBioT development assets. In exchange for a 40%, but non-controlling interest in Refuel, GMG contributed its ownership interests in EWV and $3,500,000 in cash. During the nine months ended September 30, 2019, GMG made an additional capital contribution into Refuel. In connection with GMG’s additional investment, the Company made an additional $2,100,000 investment in Refuel. During 2018 GMG acquired as regional waste management entity, Apple Valley Waste (“AVW”), with operations located in West Virginia, Maryland and Pennsylvania. As part of this acquisition, GMG also acquired its interests in EWV that were contributed to Refuel. Prior to GMG’s acquisition of AVW and the Company’s investments and control acquisition of EWV, in order for EWV to receive the proceeds from the Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Note 11), EWV and AWV had entered into several agreements. Business Services Agreement – On February 2, 2016, EWV and AVW entered into an agreement that whereby AVW provides solicitation, logistics management, human resources, accounting and financial management, and other general administrative and support services. This agreement has a ten-year term with automatic renewals for five-year periods, subject to prior notice of non-renewal. The agreement provides for a fee of $72,000 annually during construction and $367,600 annually upon commencement of operations. External costs incurred on behalf of EWV that are paid by AVW are rebilled at cost to EWV. Solid Waste Delivery / Disposal Agreements – On November 30, 2015 EWV and several AVW subsidiaries (the “Subsidiaries”) entered into agreements that provide that the Subsidiaries will deliver a minimum tonnage of municipal solid waste (52,000 tons) and that EWV will accept up to 66,250 tons of municipal solid waste. The contracts with minimum delivery tonnage have disposal fees (tipping fees) with a weighted average price of $56.37 per ton, subject to change annually. The contracts also provide that if the Subsidiaries fail to deliver the minimum tonnage, they will pay a fee of $20 for each shortfall ton. The contracts also provide that if EWV refuses to accept tonnage presented for disposal within the minimum tonnage that EWV will pay the Subsidiaries a fee of $20 per each refused ton. Each of the agreements has a ten-year term with automatic renewals for five-year periods, subject to prior notice of non-renewal. The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. September 30, December 31, 2019 2018 Assets: Accounts receivable (a) (b) (c) $ 915,171 $ 168,588 Intangible assets, net, included in other assets (d) 45,449 83,933 Liabilities: Accounts payable (d) (e) (f) (g) 1,563,705 160,761 Accrued interest payable 61,632 46,796 Long term accrued interest (h) 1,390,380 1,305,251 Advance from related party (i) 210,000 — Junior promissory note (h) 942,214 926,211 Other: Line of credit guarantee (j) 1,478,340 1,469,330 The table below presents direct related party expenses or transactions for the three and nine months ended September 30, 2019 and 2018. Compensation and related costs for employees of the Company are excluded from the table below. Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Management advisory and other fees (a) (b) $ 250,000 $ 360,393 $ 750,000 $ 794,718 HEBioT revenue (c) 590,262 — 831,274 — Operating expenses - HEBioT (e) 210,709 — 354,733 — Operating expenses – Rental Expenses (f) 24,537 30,784 73,611 78,564 Operating expenses - Selling, general and administrative (d) (g) 110,650 50,000 258,050 150,000 Interest expense 76,611 57,890 194,266 262,089 Debt guarantee fees (j) 16,875 31,250 50,625 52,083 Cost of revenue, inventory or equipment on operating leases acquired (d) — 2,720 — 14,525 (a) Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG. (b) Project Fees – In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations. (c) HEBioT Disposal Revenues – Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility. (d) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market. (e) Disposal costs – A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility. (f) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of September 30, 2019 under these operating leases total $67,082, with $25,156 due in 2019 and $41,926 due in 2020. (g) Business Services Fees – A GMG subsidiary provides certain general management and administrative support to the HEBioT facility. (h) Junior Promissory Note – See Note 10. (i) Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (j) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt. (k) Consulting Revenue - The Company provided environmental and project consulting to Entsorga West Virginia LLC, an entity that the Company accounted for as an equity investment from March 2017 through December 14, 2018, the date of its control acquisition.

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	9 Months Ended
	Sep. 30, 2019
Supplemental Consolidated Statement of Cash Flows Information
Supplemental Consolidated Statement of Cash Flows Information	Note 17. Supplemental Consolidated Statement of Cash Flows Information Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows. Nine months ended September 30, 2019 2018 Changes in operating assets and liabilities: Accounts receivable $ (1,335,024) $ (90,884) Inventory (181,979) (905,043) Prepaid expenses and other assets (3,300) (14,216) Accounts payable 3,111,285 336,315 Accrued interest payable (260,046) 377,709 Accrued expenses (2,504,724) (350,867) Deferred revenue (1,131) 15,206 Customer deposits 37,109 (16,937) Net change in operating assets and liabilities $ (1,137,810) $ (648,717) Supplementary cash flow information: Cash paid during the periods for: Interest $ 2,625,018 $ 378,431 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 259,449 $ 437,223 Common stock issued in settlement of accrued interest — 915,700 Common stock issued in acquisition of Gold Medal Group, LLC — 2,250,000 Conversion of notes into common stock — 9,090,375 Conversion of Series B preferred stock into common stock — 1,767,371 In-Kind payments by investors for common and preferred stock — 341,998 Conversion of Series A preferred stock into common stock 90,000 433,445 Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable — 5,319,777 Accrual of Series A preferred stock dividends 140,631 66,958 Payment of Series A preferred stock dividends in common stock 50,000 — Reconciliation of Cash and Restricted Cash: Cash $ 3,434,089 $ 384,403 Restricted cash (short term) 1,128,716 — Restricted cash (non-current) 2,544,948 — Total cash and restricted cash at the end of the period $ 7,107,753 $ 384,403

Recent Accounting Standards

Recent Accounting Standards	9 Months Ended
	Sep. 30, 2019
Recent Accounting Standards
Recent Accounting Standards	Note 18. Recent Accounting Standards During the nine months ended September 30, 2019, the Company adopted the following recent accounting standards: In February 2016, the FASB issued new lease accounting guidance (ASU No. 2016‑02, Leases), which has subsequently been amended by ASU No. 2018‑11, Leases in July 2018. Under the new guidance, at the commencement date, lessees will be required to recognize a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new guidance is not applicable for leases with a term of 12 months or less. Lessor accounting is largely unchanged. Public business entities should apply the amendments in ASU 2016‑02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. ASU 2018‑11 provides that under certain instances lessors may not be required to separate the components of the contracts. As a lessor of digester equipment under operating leases, the new guidance did not have a material impact on the financial statements. As a lessee under operating leases the adoption did not have a material impact on our financial statements, resulting in an increase of 2% to each of our total assets and total liabilities on our balance sheet, and had an immaterial impact to retained earnings as of the beginning of 2019. See Note 15. In March 2019, the FASB issued ASU 2019‑01, Leases (Topic 842, Codification Improvements ), which removed the requirement for an entity to disclose in the interim periods after adoption, the effect of the change on income from continuing operations, net income, any other affected financial statement line item, or per share amount. For lessors, the new leasing standard requires leases to be classified as sales-type, direct financing or operating leases. These criteria focus on the transfer of control of the underlying asset. This standard and related updates were effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2019‑01 on January 2019. See Note 15 for disclosures related to this amended guidance. The Company has not yet implanted the following accounting standards: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2019. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events
Subsequent Events	Note 19. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Condensed Consolidating Financi

Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2019
Condensed Consolidating Financial Information
Condensed Consolidating Financial Information	Note 20. Condensed Consolidating Financial Information The WVEDA Solid Waste Disposal Revenue Bond obligations of Entsorga West Virginia LLC are not guaranteed by its members, including the Company, however the membership interests of Entsorga West Virginia LLC are pledged, and the debt agreements provide restrictions prohibiting distributions to the members, including equity distributions or providing loans or advances to the members. The following pages present the Company’s consolidating balance sheet as of September 30, 2019 and December 31, 2018 and its condensed consolidating statement of operations for the three and nine months ended September 30, 2019, and cash flows for the nine months ended September 30, 2019, for Entsorga West Virginia LLC and the Parent and other Company subsidiaries not subject to the WVEDA Solid Waste Disposal Revenue Bond restrictions and the elimination entries necessary to present the Company’s financial statements on a consolidated basis. These following condensed consolidating financial information should be read in conjunction with the Company’s consolidated financial statements. Condensed Consolidating Balance Sheet as of September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 3,399,754 $ 34,335 $ — $ 3,434,089 Restricted cash — 1,128,716 — 1,128,716 Other current assets 1,408,880 899,102 (189,551) 2,118,431 Current assets 4,808,634 2,062,153 (189,551) 6,681,236 Restricted cash — 2,544,948 — 2,544,948 HEBioT facility — 36,806,051 — 36,806,051 Other fixed assets 1,711,208 — — 1,711,208 Operating lease right of use assets 81,104 889,791 — 970,895 MBT facility development and license costs 6,221,767 1,837,000 — 8,058,767 Intangible assets, net and investment in subsidiaries 10,278,558 — (10,278,558) — Goodwill — 58,000 — 58,000 Other assets 58,949 — — 58,949 Total assets $ 23,160,220 $ 44,197,943 $ (10,468,109) $ 56,890,054 Liabilities and stockholders’ equity Line of credit $ 1,478,340 $ — $ — $ 1,478,340 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,211,697 4,153,724 (189,551) 6,175,870 Current liabilities 3,690,037 5,543,724 (189,551) 9,044,210 Notes payable and other debts 5,032,423 — — 5,032,423 Accrued interest 1,390,380 — — 1,390,380 Non-current lease liabilities — 913,367 — 913,367 WV EDA bonds — 29,717,377 — 29,717,377 Total liabilities 10,112,840 36,174,468 (189,551) 46,097,757 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 3,922,118 — — 3,922,118 Attributable to non-controlling interests 8,398,709 8,023,475 (10,278,558) 6,143,626 Stockholders’ equity 12,320,827 8,023,475 (10,278,558) 10,065,744 Total liabilities and stockholders’ equity $ 23,160,220 $ 44,197,943 $ (10,468,109) $ 56,890,054 Condensed Consolidating Statement of Operations for the three months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 816,870 $ 609,905 $ — $ 1,426,775 Operating expenses HEBioT — 786,680 — 786,680 Rental, service and maintenance expense 176,651 — — 176,651 Equipment sales 17,776 — — 17,776 Selling, general and administrative 1,203,519 246,026 — 1,449,545 Depreciation and amortization 120,899 490,469 — 611,368 Total operating expenses 1,518,845 1,523,175 — 3,042,020 Loss from operations (701,975) (913,270) — (1,615,245) Other (income) expenses, net (180,837) 600,402 — 419,565 Net loss $ (521,138) $ (1,513,672) $ — $ (2,034,810) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 2,325,742 $ 886,947 $ — $ 3,212,689 Operating expenses HEBioT — 1,309,176 — 1,309,176 Rental, service and maintenance expense 508,164 — — 508,164 Equipment sales 56,502 — — 56,502 Selling, general and administrative 4,678,415 771,867 — 5,450,282 Depreciation and amortization 369,843 980,937 — 1,350,780 Total operating expenses 5,612,924 3,061,980 — 8,674,904 Loss from operations (3,287,182) (2,175,033) — (5,462,215) Other expenses 273,851 1,361,221 86,362 1,721,434 Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Non-cash adjustments to reconcile net loss to net cash used in operations 1,153,022 1,064,563 86,362 2,303,947 Changes in operating assets and liabilities (697,598) (440,212) — (1,137,810) Net cash used in operations (3,105,609) (2,911,903) — (6,017,512) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment 98 (4,619,981) — (4,619,883) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 — Other investing activities 2,256,987 — — 2,256,987 Net cash used in investing activities (2,329,277) (4,619,981) 4,586,362 (2,362,896) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (6,846) — — (6,846) Deferred financing costs incurred — (62,151) — (62,151) Net cash provided by financing activities 6,411,211 4,524,211 (4,586,362) 6,349,060 Effect of exchange rate on cash 12,721 — — 12,721 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 3,399,754 $ 3,707,999 $ — $ 7,107,753 Condensed Consolidating Balance Sheet as of December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 2,410,709 $ — $ — $ 2,410,709 Restricted cash — 4,195,148 — 4,195,148 Other current assets 969,571 — — 969,571 Current assets 3,380,280 4,195,148 — 7,575,428 Restricted cash — 2,520,523 — 2,520,523 HEBioT facility under construction — 33,104,007 — 33,104,007 Other fixed assets 1,797,915 — — 1,797,915 MBT facility development and license costs 6,585,408 1,890,000 — 8,475,408 Intangible assets, net and investment in subsidiaries 7,626,268 — (5,854,952) 1,771,316 Goodwill — 58,000 — 58,000 Other assets 13,500 — — 13,500 Total assets $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 Liabilities and stockholders’ equity Line of credit $ 1,469,330 $ — $ — $ 1,469,330 Other current liabilities 2,032,083 3,708,410 — 5,740,493 Current liabilities 3,501,413 3,708,410 — 7,209,823 Notes payable and other debts 4,890,322 — — 4,890,322 Accrued interest 1,305,251 — — 1,305,251 WV EDA bonds — 31,085,902 — 31,085,902 Total liabilities 9,696,986 34,794,312 — 44,491,298 Redeemable preferred stock 816,553 — — 816,553 Stockholder’s equity Attributable to parent 3,405,551 5,854,952 (5,854,952) 3,405,551 Attributable to non-controlling interests 5,484,281 1,118,414 — 6,602,695 Stockholders’ equity 8,889,832 6,973,366 (5,854,952) 10,008,246 Total liabilities and stockholders’ equity $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 No condensed consolidating statements of operations and of cash flows are presented prior to the December 14, 2018 control acquisition of Entsorga West Virginia, LLC.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, valuation of deferred tax assets, share based compensation, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including intangibles, and useful lives and other provisions and contingencies.
Foreign Operations	Foreign Operations — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables.
Product and Services Revenue Recognition	Product and Services Revenue Recognition — The Company records revenue based on a five-step model in accordance with ASC 606, Revenue from Contracts with Customers, which require that we: 1. Identify the contract with a customer; 2. Identify the performance obligations in the contract; 3. Determine the transaction price of the contract; 4. Allocate the transaction price to the performance obligations in the contract; 5. Recognize revenue when the performance obligations are met or delivered. When revenue is earned based on product sales, such as sales of digester equipment and parts, solid recovered fuel and recycled materials, the Company’s performance obligations are satisfied at the point in time when products are shipped to the customer, which is when the customer has title and control. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of products. When revenue is earned based on receipt of disposal waste, the Company's performance obligations are satisfied at the point in time when disposal waste products are received from the customer, which is when the Company has title and control. Therefore, the Company's contracts have a single performance obligation (receipt of disposal waste). When revenue is earned on services, such as management advisory fees and digester maintenance and repair services fees are recognized over the period the services are performed based on service milestones. The Company records taxes collected from customers and remitted to governmental authorities on a net basis.
Lease Revenue Recognition	Lease Revenue Recognition — Rental, service and maintenance revenues relating to the Company’s rental agreements involve providing use of the Company’s digesters at customer locations, access to our software as a service and preventative maintenance over the term. The agreements generally provide for flat monthly payments that the Company believes are consistent with our costs and obligations underlying the agreements. The Company selected the practical expedient not to separate non-lease components from lease components. The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: · The lease transfers ownership of the underlying asset to the lessee by the end of the lease term, · The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise, · The Lease term is for the major part of the remaining economic life of the underlying asset. However, if the commencement date falls at or near the end of the economic life of the underlying asset, this criterion shall not be used for purposes of classifying the lease, · The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset or The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term.
Restricted Cash	Restricted Cash — Includes Restricted cash that is restricted as to its use, as it is held by a trustee in accordance with the West Virginia Economic Development Authority bond agreement. These amounts are held by the Company’s trustee in various bank accounts segregated for specific uses related to the construction and operation of the resource recovery facility. Amounts required to meet current operations of the Company have been classified as current in the accompanying consolidated balance sheets.
HEBioT Facility	HEBioT Facility — High Efficiency Biological Treatment (“HEBioT”) facility was under construction through March 31, 2019 and includes all costs incurred to bring an asset to the condition and location necessary for its intended use, with some continuing finalizations and adjustments. Included in the capitalized costs are construction, legal, leasehold improvements, and interest. Since April 1, 2019, these costs have been depreciated based on estimated lives ranging from 10 to 35 years.
MBT Facility Development Costs	MBT Facility Development Costs — The Company defers costs relating to on-going Mechanical Biological Treatment (“MBT”) facility development costs commencing upon the Company’s determination that the project will be completed. These site specific costs generally include external costs generally relating to legal, engineering and other costs relating to the acquisitions of land, permits and licenses. Upon commencement of construction, to the extent that costs relate to the facility, they are transferred to the construction in progress.
Investments in Unconsolidated Entities	Investments in Unconsolidated Entities —The Company has utilized the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. In circumstances where the Company does not have the ability to exercise significant influence or control over the operating and financial policies of the investee, the investment is carried at cost, less impairment, adjusted for subsequent changes to estimated fair value up to the original cost. As of September 30, 2019, the Company had no investments in unconsolidated investments as a result of its July 3, 3019 sale of its investment in Gold Medal Group, LLC ("GMG"), which was comprised of 2,250,000 GMG Investment Preferred Units and 2,250,000 Class A Common Units, to Gold Medal Equity, LLC ("GME"), the parent entity to GMG for total compensation of $2,250,000. As of July 3, 2019 these investments were carried by the Company with an adjusted cost of $1,687,383 resulting in a gain of $562,617 on July 3, 2019, which was recorded as gain on sale of affiliate investment in the accompanying condensed consolidated statements of operations and comprehensive loss.
Lease Revenue Recognition	Lease Revenue Recognition — Rental, service and maintenance revenues relating to the Company’s rental agreements involve providing use of the Company’s digesters at customer locations, access to our software as a service and preventative maintenance over the term. The agreements generally provide for flat monthly payments that the Company believes are consistent with our costs and obligations underlying the agreements. The Company selected the practical expedient not to separate non-lease components from lease components. The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: · The lease transfers ownership of the underlying asset to the lessee by the end of the lease term, · The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise, · The Lease term is for the major part of the remaining economic life of the underlying asset. However, if the commencement date falls at or near the end of the economic life of the underlying asset, this criterion shall not be used for purposes of classifying the lease, · The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset or The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term.
Restricted Cash	Restricted Cash — Includes Restricted cash that is restricted as to its use, as it is held by a trustee in accordance with the West Virginia Economic Development Authority bond agreement. These amounts are held by the Company’s trustee in various bank accounts segregated for specific uses related to the construction and operation of the resource recovery facility. Amounts required to meet current operations of the Company have been classified as current in the accompanying consolidated balance sheets.
HEBioT Facility	HEBioT Facility — High Efficiency Biological Treatment (“HEBioT”) facility was under construction through March 31, 2019 and includes all costs incurred to bring an asset to the condition and location necessary for its intended use, with some continuing finalizations and adjustments. Included in the capitalized costs are construction, legal, leasehold improvements, and interest. Since April 1, 2019, these costs have been depreciated based on estimated lives ranging from 10 to 35 years.
MBT Facility Development Costs	MBT Facility Development Costs — The Company defers costs relating to on-going Mechanical Biological Treatment (“MBT”) facility development costs commencing upon the Company’s determination that the project will be completed. These site specific costs generally include external costs generally relating to legal, engineering and other costs relating to the acquisitions of land, permits and licenses. Upon commencement of construction, to the extent that costs relate to the facility, they are transferred to the construction in progress.
Investments in Unconsolidated Entities	Investments in Unconsolidated Entities —The Company has utilized the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. In circumstances where the Company does not have the ability to exercise significant influence or control over the operating and financial policies of the investee, the investment is carried at cost, less impairment, adjusted for subsequent changes to estimated fair value up to the original cost. As of September 30, 2019, the Company had no investments in unconsolidated investments as a result of its July 3, 3019 sale of its investment in Gold Medal Group, LLC ("GMG"), which was comprised of 2,250,000 GMG Investment Preferred Units and 2,250,000 Class A Common Units, to Gold Medal Equity, LLC ("GME"), the parent entity to GMG for total compensation of $2,250,000. As of July 3, 2019 these investments were carried by the Company with an adjusted cost of $1,687,383 resulting in a gain of $562,617 on July 3, 2019, which was recorded as gain on sale of affiliate investment in the accompanying condensed consolidated statements of operations and comprehensive loss.
Deferred Financing Costs	Deferred Financing Costs — Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments.
Income Taxes	Income Taxes — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
Loss per Share	Loss per Share — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” Dividends attributable to preferred stock, whether declared or accrued, and deemed dividends on down round feature are deducted from income attributable to common shareholders for purposes of earnings per share. The Company’s potential dilutive instruments include convertible preferred stock, options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Acquisitions and Contribution A

Acquisitions and Contribution Agreement (Tables)	9 Months Ended
	Sep. 30, 2019
Acquisition and Contribution Agreement
Schedule of Pro forma information	The following presents unaudited pro forma information as if the acquisition had occurred as of January 1, 2018. The pro forma results do not include any anticipated cost synergies or other effects of the integration of the acquired company. Pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the dates indicated, nor is it indicative of future operating results of the combined company. For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Pro forma revenue $ 1,426,775 $ 1,088,082 $ 3,212,689 $ 2,642,946 Pro forma net loss (1,306,473) (2,243,309) (7,183,649) (13,310,199) Proforma earnings per share – basic and diluted (0.13) (0.16) (0.41) (1.02)

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	9 Months Ended
	Sep. 30, 2019
Accounts Receivable, net
Schedule of Accounts receivable	September 30, December 31, 2019 2018 Accounts receivable $ 1,675,040 $ 513,336 Less: allowance for doubtful accounts receivable (155,039) (110,038) $ 1,520,001 $ 403,298

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory
Schedule of inventory	September 30, December 31, 2019 2018 Equipment $ 156,419 $ 169,540 Parts and assemblies 272,779 330,308 $ 429,198 $ 499,848

Equipment on Operating Leases_2

Equipment on Operating Leases, net (Tables)	9 Months Ended
	Sep. 30, 2019
Equipment on Operating Leases, Net [Abstract]
Schedule of property subject to or available for operating lease	Equipment on operating leases consist of the following: September 30, December 31, 2019 2018 Leased equipment $ 3,117,960 $ 3,054,097 Less: accumulated depreciation (1,440,846) (1,305,210) $ 1,677,114 $ 1,748,887
Schedule Of future minimum rental payments receivable for operating leases	The minimum future estimated contractual payments to be received under these leases as of September 30, 2019 is as follows: Year ending December 31, 2019 (remaining) $ 382,069 2020 1,259,264 2021 920,137 2022 644,860 2023 and thereafter 468,856 Total minimum future lease income as of September 30, 2019 $ 3,675,186

MBT Facility Development and _2

MBT Facility Development and License Costs (Tables)	9 Months Ended
	Sep. 30, 2019
MBT Facility Development and License Costs
Schedule of MBT facility development and license costs	MBT Facility Development and License Costs consist of the following: September 30, December 31, 2019 2018 MBT Projects New Windsor, New York: Land acquisition $ — $ 66,000 Legal — 46,030 Survey and engineering — 300,624 — 412,654 Rensselaer, New York: Survey and engineering 212,567 153,554 Total MBT projects 212,567 566,208 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $63,000 of amortization as of September 30, 2019 1,827,000 1,890,000 Total Technology Licenses 7,846,200 7,909,200 Total MBT Facility Development and License Costs $ 8,058,767 $ 8,475,408

Risk Concentrations (Tables)

Risk Concentrations (Tables)	9 Months Ended
	Sep. 30, 2019
Risk Concentrations
Schedule of revenue from external customers by geographic areas	The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2019: Revenue, for the nine months ended September 30, 2019 $ 2,877,157 $ 335,532 $ 3,212,689 Revenue, for the three months ended September 30, 2019 1,333,878 92,897 1,426,775 Non-current tangible assets, as of September 30, 2019 40,802,758 259,449 41,062,207 2018: Revenue, for the nine months ended September 30, 2018 $ 2,333,242 $ 309,704 $ 2,642,946 Revenue, for the three months ended September 30, 2018 939,503 148,579 1,088,082 Non-current tangible assets, as of December 31, 2018 34,630,978 284,444 34,915,422

Line of Credit, Notes Payable_2

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2019
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt
Schedule of long-term debt	Notes, lines, advances and long-term debts are comprised of the following: September 30, 2019 December 31, 2018 Related Related Total Party Total Party Line of credit $ 1,478,340 $ — $ 1,469,330 $ — Senior secured promissory note 4,080,947 — 3,851,305 — Junior promissory note 942,214 942,214 926,211 926,211 Note payable 100,000 — 100,000 — Advance from related party 210,000 210,000 — — Long term debt - current and long-term portion 15,125 — 21,971 —
Schedule of maturities of long-term debts	Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — as of September 30, 2019, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2019 (remaining) $ 2,319 $ — $ 2,319 2020 4,605 100,000 104,605 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 and thereafter — 1,669,477 1,669,477 Total $ 15,125 $ 6,144,477 $ 6,159,602

Entsorga West Virginia, LLC W_2

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Tables)	9 Months Ended
	Sep. 30, 2019
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Schedule of future sinking fund payments by the borrower	The future sinking fund payments by the Borrower as of September 30, 2019 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2019 (remaining) $ — $ — $ — $ — 2020 1,160,000 — 230,000 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 and thereafter 4,260,000 17,465,000 7,240,000 28,965,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000

Equity and Equity Transactions

Equity and Equity Transactions (Tables)	9 Months Ended
	Sep. 30, 2019
Equity and Equity Transactions
Schedule of preferred units	As of September 30, 2019 and December 31, 2018, 17,163,400 and 14,802,956 shares of common stock have been issued; and 3,179,120 and 3,159,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,018,375 in accumulated, but undeclared preferential dividends as of September 30, 2019, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value September 30, 2019 December 31, 2018 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 163,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 18,850 — Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 564,519
Schedule of share-based compensation, activity	the Company has the 4,674,261 warrants to acquire the Company’s common stock outstanding as of September 30, 2019, as follows: Weighted Expiring During the Year Exercise Price Average Price Ending December 31, Warrant Shares per Share per Share 2020 22,860 $3.50 $3.50 2021 1,768,516 $1.80 to $3.30 $3.25 2022 1,699,861 $1.80 to $5.00 $2.60 2023 740,749 $1.80 $1.80 2024 385,945 $1.80 $1.80 2025 56,330 $2.25 $2.25
Schedule of warrants or rights outstanding	The following table summarizes the outstanding warrant activity through September 30, 2019: Outstanding, January 1, 2019 4,201,736 Issued 442,275 Issued as a result of common stock offering at $1.80 per share 30,250 Exercised — Expired — Outstanding, September 30, 2019 4,674,261

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2019
Equity Incentive Plans
Schedule of compensation expenses related to stock options	Compensation expense related to stock options and restricted stock was: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Stock options $ 31,323 $ 68,264 $ 104,075 $ 115,530 Restricted stock 178,262 262,064 637,113 369,714 Total $ 209,585 $ 330,328 $ 741,188 $ 485,244
Schedule of compensation expenses related to stock options and restricted stock	Compensation expense related to stock options and restricted stock was reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Rental, service and maintenance $ 3,353 $ 8,406 $ 12,426 $ 17,075 Selling, general and administrative 206,232 321,922 728,762 468,169 Total $ 209,585 $ 330,328 $ 741,188 $ 485,244
Schedule of restricted stock	There were no grants of options or restricted stock during the three and nine months ended September 30, 2019. Unvested restricted stock activity was: Balance, January 1, 2019 742,741 Grants — Forfeited (40,120) Vested (295,053) Balance, September 30, 2019 407,568

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Research And Development Lease [Member]
Schedule of Maturities of lease liabilities	Maturities of lease liabilities under these leases, which have a weighted average remaining term of 25.1 years, as of September 30, 2019 is: Year Ending December 31, 2019 (remaining) $ 51,406 2020 146,926 2021 109,000 2022 113,000 2023 and thereafter 3,093,750 Total lease payments 3,514,082 Less imputed interest (2,431,140) Present value of lease liabilities $ 1,082,942

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2019
Related Party Transactions
Schedule of related party transactions	The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. September 30, December 31, 2019 2018 Assets: Accounts receivable (a) (b) (c) $ 915,171 $ 168,588 Intangible assets, net, included in other assets (d) 45,449 83,933 Liabilities: Accounts payable (d) (e) (f) (g) 1,563,705 160,761 Accrued interest payable 61,632 46,796 Long term accrued interest (h) 1,390,380 1,305,251 Advance from related party (i) 210,000 — Junior promissory note (h) 942,214 926,211 Other: Line of credit guarantee (j) 1,478,340 1,469,330 The table below presents direct related party expenses or transactions for the three and nine months ended September 30, 2019 and 2018. Compensation and related costs for employees of the Company are excluded from the table below. Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Management advisory and other fees (a) (b) $ 250,000 $ 360,393 $ 750,000 $ 794,718 HEBioT revenue (c) 590,262 — 831,274 — Operating expenses - HEBioT (e) 210,709 — 354,733 — Operating expenses – Rental Expenses (f) 24,537 30,784 73,611 78,564 Operating expenses - Selling, general and administrative (d) (g) 110,650 50,000 258,050 150,000 Interest expense 76,611 57,890 194,266 262,089 Debt guarantee fees (j) 16,875 31,250 50,625 52,083 Cost of revenue, inventory or equipment on operating leases acquired (d) — 2,720 — 14,525 (a) Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG. (b) Project Fees – In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations. (c) HEBioT Disposal Revenues – Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility. (d) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market. (e) Disposal costs – A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility. (f) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of September 30, 2019 under these operating leases total $67,082, with $25,156 due in 2019 and $41,926 due in 2020. (g) Business Services Fees – A GMG subsidiary provides certain general management and administrative support to the HEBioT facility. (h) Junior Promissory Note – See Note 10. (i) Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (j) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt. (k) Consulting Revenue - The Company provided environmental and project consulting to Entsorga West Virginia LLC, an entity that the Company accounted for as an equity investment from March 2017 through December 14, 2018, the date of its control acquisition.

Supplemental Consolidated Sta_2

Supplemental Consolidated Statement of Cash Flows Information (Tables)	9 Months Ended
	Sep. 30, 2019
Supplemental Consolidated Statement of Cash Flows Information
Schedule of supplemental cash flow	Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows. Nine months ended September 30, 2019 2018 Changes in operating assets and liabilities: Accounts receivable $ (1,335,024) $ (90,884) Inventory (181,979) (905,043) Prepaid expenses and other assets (3,300) (14,216) Accounts payable 3,111,285 336,315 Accrued interest payable (260,046) 377,709 Accrued expenses (2,504,724) (350,867) Deferred revenue (1,131) 15,206 Customer deposits 37,109 (16,937) Net change in operating assets and liabilities $ (1,137,810) $ (648,717) Supplementary cash flow information: Cash paid during the periods for: Interest $ 2,625,018 $ 378,431 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 259,449 $ 437,223 Common stock issued in settlement of accrued interest — 915,700 Common stock issued in acquisition of Gold Medal Group, LLC — 2,250,000 Conversion of notes into common stock — 9,090,375 Conversion of Series B preferred stock into common stock — 1,767,371 In-Kind payments by investors for common and preferred stock — 341,998 Conversion of Series A preferred stock into common stock 90,000 433,445 Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable — 5,319,777 Accrual of Series A preferred stock dividends 140,631 66,958 Payment of Series A preferred stock dividends in common stock 50,000 — Reconciliation of Cash and Restricted Cash: Cash $ 3,434,089 $ 384,403 Restricted cash (short term) 1,128,716 — Restricted cash (non-current) 2,544,948 — Total cash and restricted cash at the end of the period $ 7,107,753 $ 384,403

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2019
Condensed Consolidating Financial Information
Schedule of condensed financial statements	Condensed Consolidating Balance Sheet as of September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 3,399,754 $ 34,335 $ — $ 3,434,089 Restricted cash — 1,128,716 — 1,128,716 Other current assets 1,408,880 899,102 (189,551) 2,118,431 Current assets 4,808,634 2,062,153 (189,551) 6,681,236 Restricted cash — 2,544,948 — 2,544,948 HEBioT facility — 36,806,051 — 36,806,051 Other fixed assets 1,711,208 — — 1,711,208 Operating lease right of use assets 81,104 889,791 — 970,895 MBT facility development and license costs 6,221,767 1,837,000 — 8,058,767 Intangible assets, net and investment in subsidiaries 10,278,558 — (10,278,558) — Goodwill — 58,000 — 58,000 Other assets 58,949 — — 58,949 Total assets $ 23,160,220 $ 44,197,943 $ (10,468,109) $ 56,890,054 Liabilities and stockholders’ equity Line of credit $ 1,478,340 $ — $ — $ 1,478,340 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,211,697 4,153,724 (189,551) 6,175,870 Current liabilities 3,690,037 5,543,724 (189,551) 9,044,210 Notes payable and other debts 5,032,423 — — 5,032,423 Accrued interest 1,390,380 — — 1,390,380 Non-current lease liabilities — 913,367 — 913,367 WV EDA bonds — 29,717,377 — 29,717,377 Total liabilities 10,112,840 36,174,468 (189,551) 46,097,757 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 3,922,118 — — 3,922,118 Attributable to non-controlling interests 8,398,709 8,023,475 (10,278,558) 6,143,626 Stockholders’ equity 12,320,827 8,023,475 (10,278,558) 10,065,744 Total liabilities and stockholders’ equity $ 23,160,220 $ 44,197,943 $ (10,468,109) $ 56,890,054 Condensed Consolidating Balance Sheet as of December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 2,410,709 $ — $ — $ 2,410,709 Restricted cash — 4,195,148 — 4,195,148 Other current assets 969,571 — — 969,571 Current assets 3,380,280 4,195,148 — 7,575,428 Restricted cash — 2,520,523 — 2,520,523 HEBioT facility under construction — 33,104,007 — 33,104,007 Other fixed assets 1,797,915 — — 1,797,915 MBT facility development and license costs 6,585,408 1,890,000 — 8,475,408 Intangible assets, net and investment in subsidiaries 7,626,268 — (5,854,952) 1,771,316 Goodwill — 58,000 — 58,000 Other assets 13,500 — — 13,500 Total assets $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 Liabilities and stockholders’ equity Line of credit $ 1,469,330 $ — $ — $ 1,469,330 Other current liabilities 2,032,083 3,708,410 — 5,740,493 Current liabilities 3,501,413 3,708,410 — 7,209,823 Notes payable and other debts 4,890,322 — — 4,890,322 Accrued interest 1,305,251 — — 1,305,251 WV EDA bonds — 31,085,902 — 31,085,902 Total liabilities 9,696,986 34,794,312 — 44,491,298 Redeemable preferred stock 816,553 — — 816,553 Stockholder’s equity Attributable to parent 3,405,551 5,854,952 (5,854,952) 3,405,551 Attributable to non-controlling interests 5,484,281 1,118,414 — 6,602,695 Stockholders’ equity 8,889,832 6,973,366 (5,854,952) 10,008,246 Total liabilities and stockholders’ equity $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097
Schedule of condensed income statement	Condensed Consolidating Statement of Operations for the three months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 816,870 $ 609,905 $ — $ 1,426,775 Operating expenses HEBioT — 786,680 — 786,680 Rental, service and maintenance expense 176,651 — — 176,651 Equipment sales 17,776 — — 17,776 Selling, general and administrative 1,203,519 246,026 — 1,449,545 Depreciation and amortization 120,899 490,469 — 611,368 Total operating expenses 1,518,845 1,523,175 — 3,042,020 Loss from operations (701,975) (913,270) — (1,615,245) Other (income) expenses, net (180,837) 600,402 — 419,565 Net loss $ (521,138) $ (1,513,672) $ — $ (2,034,810) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 2,325,742 $ 886,947 $ — $ 3,212,689 Operating expenses HEBioT — 1,309,176 — 1,309,176 Rental, service and maintenance expense 508,164 — — 508,164 Equipment sales 56,502 — — 56,502 Selling, general and administrative 4,678,415 771,867 — 5,450,282 Depreciation and amortization 369,843 980,937 — 1,350,780 Total operating expenses 5,612,924 3,061,980 — 8,674,904 Loss from operations (3,287,182) (2,175,033) — (5,462,215) Other expenses 273,851 1,361,221 86,362 1,721,434 Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649)
Schedule of condensed cash flow Statement	Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Non-cash adjustments to reconcile net loss to net cash used in operations 1,153,022 1,064,563 86,362 2,303,947 Changes in operating assets and liabilities (697,598) (440,212) — (1,137,810) Net cash used in operations (3,105,609) (2,911,903) — (6,017,512) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment 98 (4,619,981) — (4,619,883) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 — Other investing activities 2,256,987 — — 2,256,987 Net cash used in investing activities (2,329,277) (4,619,981) 4,586,362 (2,362,896) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (6,846) — — (6,846) Deferred financing costs incurred — (62,151) — (62,151) Net cash provided by financing activities 6,411,211 4,524,211 (4,586,362) 6,349,060 Effect of exchange rate on cash 12,721 — — 12,721 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 3,399,754 $ 3,707,999 $ — $ 7,107,753

Basis of Presentation and Goi_2

Basis of Presentation and Going Concern (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (2,034,810)	$ (1,997,127)	$ (7,183,649)	$ (12,713,891)
Operating Income (Loss)	(1,615,245)	(1,177,278)	(5,462,215)	(3,735,835)
Net Cash Provided by (Used in) Operating Activities			(6,017,512)	(4,386,230)
Working Capital Deficit			2,362,974
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	10,065,744		10,065,744			$ 10,008,246
Stockholders' Equity Attributable to Parent	3,922,118	$ 2,981,820	3,922,118	2,981,820	$ 1,880,500	$ 3,405,551	$ 4,246,792
Proceeds from common stock issuance, net of offering costs	$ 3,035,557		$ 3,035,557	$ 0
Refuel America LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage	60.00%		60.00%
Entsorgia West Virginia LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage	88.70%		88.70%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Jul. 03, 2019	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Total compensation	$ 2,250,000
Carrying value of investments	1,687,383			$ 0
Gain on sale of affiliate	$ 562,617	$ 562,617	$ 0	$ 562,617	$ 0
Preferred Units [Member]
Number of stock sold	2,250,000
Class A Common Units [Member]
Number of stock sold	2,250,000
HEBioT Facility WV [Member] | Maximum [Member]
Estimated Blended Life For Facility		35 years
HEBioT Facility WV [Member] | Minimum [Member]
Estimated Blended Life For Facility		10 years

Acquisition and Contribution _2

Acquisition and Contribution Agreement (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Acquisition and Contribution Agreement
Pro forma revenue	$ 1,426,775	$ 1,088,082	$ 3,212,689	$ 2,642,946
Pro forma net loss	$ (1,306,473)	$ (2,243,309)	$ (7,183,649)	$ (13,310,199)
Proforma earnings per share - basic and diluted	$ (0.13)	$ (0.16)	$ (0.41)	$ (1.02)

Acquisition and Contribution _3

Acquisition and Contribution Agreement - Additional Information (Details) - USD ($)	Jul. 03, 2019	Dec. 14, 2018	Nov. 28, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2017
Royalty Guarantees, Commitments, Amount		$ 6,019,200
Interest Costs Capitalized		316,207
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest				$ (2,034,810)	$ (1,997,127)	$ (7,183,649)	$ (12,713,891)
Legal Fees						135,359
Adjusted cost	$ 1,687,383					0
Pro forma revenue				1,426,775	1,088,082	3,212,689	2,642,946
Pro forma net loss				$ (1,306,473)	$ (2,243,309)	$ (7,183,649)	$ (13,310,199)
Gold Medal Group, LLC [Member]
Cash Contribution		$ 3,500,000
Entsorga West Virginia LLC [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		714,519
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 1,886,630
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination		2,863,583
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		$ 976,953
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions						4,410.4
Sale of Stock, Number of Shares Issued in Transaction		2,687						1,723.4
Equity Method Investment, Ownership Percentage				44.10%		44.10%
Number of stock sold		2,687						1,723.4
Entsorga West Virginia LLC [Member] | Gold Medal Group, LLC [Member]
Equity Method Investment, Ownership Percentage				34.10%		34.10%
Refuel America LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired		60.00%
Refuel America LLC [Member] | Gold Medal Group, LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired		40.00%
Entsorga USA Inc [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			714,519
Sale of Stock, Number of Shares Issued in Transaction			2,687
Equity Method Investment, Ownership Percentage		44.10%
Number of stock sold			2,687
Entsorga USA Inc [Member] | Gold Medal Group, LLC [Member]
Equity Method Investment, Ownership Percentage		34.10%

Accounts Receivable, net (Detai

Accounts Receivable, net (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Accounts Receivable, net
Accounts receivable	$ 1,675,040	$ 513,336
Less: allowance for doubtful accounts receivable	(155,039)	(110,038)
Accounts Receivable, Net, Current, Total	$ 1,520,001	$ 403,298

Inventory (Details)

Inventory (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Inventory [Line Items]
Inventory, Net, Total	$ 429,198	$ 499,848
Equipment [Member]
Inventory [Line Items]
Inventory, Net, Total	156,419	169,540
Parts and assemblies [Member]
Inventory [Line Items]
Inventory, Net, Total	$ 272,779	$ 330,308

Equipment on Operating Leases_3

Equipment on Operating Leases, net (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Property Subject to or Available for Operating Lease, Net, Total	$ 1,677,114	$ 1,748,887
Assets Held under Operating Leases [Member]
Leased equipment	3,117,960	3,054,097
Less: accumulated depreciation	(1,440,846)	(1,305,210)
Property Subject to or Available for Operating Lease, Net, Total	$ 1,677,114	$ 1,748,887

Equipment on Operating Leases_4

Equipment on Operating Leases, net - Minimum Future Estimated Contractual Payments to be Received (Details)	Sep. 30, 2019USD ($)
Leases
2019 (remaining)	$ 382,069
2020	1,259,264
2021	920,137
2022	644,860
2023 and thereafter	468,856
Total minimum lease income	$ 3,675,186

Equipment on Operating Leases_5

Equipment on Operating Leases, net - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Depreciation	$ 110,795	$ 94,967	$ 316,061	$ 267,229
Eco Safe digester [Member]
Operating Leases, Income Statement, Lease Revenue, Total	$ 369,437	$ 299,537	$ 1,061,289	$ 852,675

HEBioT Facility (Details)

HEBioT Facility (Details) - USD ($)	Dec. 14, 2018	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2019
Interest Costs Capitalized	$ 316,207
HEBioT Facility WV [Member]
Interest Costs Capitalized			$ 618,706
Depreciation		$ 458,968		$ 917,937
HEBioT Facility WV [Member] | Minimum [Member] | Construction in Progress [Member]
Estimated lives ranging				10 years
HEBioT Facility WV [Member] | Maximum [Member] | Construction in Progress [Member]
Estimated lives ranging				35 years

MBT Facility Development and _3

MBT Facility Development and License Costs (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Land and Land Improvements	$ 8,058,767	$ 8,475,408
New Windsor Site [Member]
Land and Land Improvements	0	412,654
MBT Projects Member [Member]
Land and Land Improvements	212,567	566,208
land Acquisition Costs [Member] | New Windsor Site [Member]
Land and Land Improvements	0	66,000
Legal Cost [Member] | New Windsor Site [Member]
Land and Land Improvements	0	46,030
Survey and Engineering Costs [Member] | New Windsor Site [Member]
Land and Land Improvements	0	300,624
Survey and Engineering Costs [Member] | Rensselaer [Member]
Land and Land Improvements	212,567	153,554
Technology Licenses Cost [Member]
Land and Land Improvements	7,846,200	7,909,200
Technology Licenses Cost [Member] | Future Site [Member]
Land and Land Improvements	6,019,200	6,019,200
Technology Licenses Cost [Member] | Martinsburg West Virginia [Member]
Land and Land Improvements	$ 1,827,000	$ 1,890,000

MBT Facility Development and _4

MBT Facility Development and License Costs - Additional Information (Details)	Sep. 09, 2019$ / sharesshares	Dec. 14, 2018USD ($)	Nov. 01, 2017USD ($)t	Sep. 30, 2019USD ($)$ / shares	Mar. 31, 2019USD ($)	Sep. 30, 2019USD ($)$ / shares	Sep. 26, 2019$ / shares	Dec. 31, 2018$ / shares
Royalty Guarantees, Commitments, Amount		$ 6,019,200
Stock Issued During Period, Shares, New Issues | shares	1,877,666
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Biological Treatment Waste Capacity | t			165,000
Payments For Rescinded Contract					$ 66,000
Intellectual Property [Member] | Entsorgafin S.p.A [Member]
Royalty Guarantees, Commitments, Amount			$ 6,019,200
Lease Agreements [Member]
Finite-lived Intangible Assets Acquired		$ 1,890,000
Finite-Lived Intangible Assets, Remaining Amortization Period						15 years
Amortization Expenses				$ 31,500		$ 63,000
Selling, General and Administrative Expenses [Member] | Land [Member]
Asset Impairment Charges					$ 346,654

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Concentration Risk [Line Items]
Revenue	$ 1,426,775	$ 1,088,082	$ 3,212,689	$ 2,642,946
Non-current tangible assets	41,062,207		41,062,207		$ 34,915,422
United States [Member]
Concentration Risk [Line Items]
Revenue	1,333,878	939,503	2,877,157	2,333,242
Non-current tangible assets	40,802,758		40,802,758		34,630,978
International [Member]
Concentration Risk [Line Items]
Revenue	92,897	$ 148,579	335,532	$ 309,704
Non-current tangible assets	$ 259,449		$ 259,449		$ 284,444

Risk Concentrations - Additiona

Risk Concentrations - Additional Information (Details)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Vendor One [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	21.50%
Gold Medal Group [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Ownership Percentage by Parent	40.00%			40.00%
Sales Revenue, Net [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	58.90%		31.30%	49.20%	38.00%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%		10.00%	10.00%	10.00%
Accounts Receivable [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		32.80%		59.60%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%		10.00%
Accounts Payable [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage						1.40%
Accounts Payable [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				37.20%		12.00%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				10.00%		10.00%
Cost Of Revenue [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	16.30%		10.10%	16.30%	12.10%
Cost Of Revenue [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	1.20%		1.20%	1.20%	1.20%
Cost Of Revenue [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			18.90%	11.90%	28.70%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%			10.00%
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%		10.00%

Line of Credit, Notes Payable_3

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt (Details) - USD ($)		Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Line of credit		$ 1,478,340	$ 1,469,330
Senior secured promissory note		4,080,947	3,851,305
Junior promissory note		942,214	926,211
Notes payable		100,000	100,000
Advance from related party		210,000	0
Long term debt - current and long-term portion		15,125	21,971
Related Party [Member]
Debt Instrument [Line Items]
Line of credit		0	0
Senior secured promissory note		0	0
Junior promissory note		942,214	926,211
Notes payable		0	0
Advance from related party	[1]	210,000	0
Long term debt - current and long-term portion		$ 0	$ 0
[1]	Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.

Line of Credit, Notes Payable_4

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt - Maturities of Long Term Debts (Details)	Sep. 30, 2019USD ($)
2019 (remaining)	$ 2,319
2020	104,605
2021	1,879,380
2022	2,503,821
2023 and thereafter	1,669,477
Total	6,159,602
Amortizing [Member]
2019 (remaining)	2,319
2020	4,605
2021	4,380
2022	3,821
2023 and thereafter	0
Total	15,125
Non-Amortizing [Member]
2019 (remaining)	0
2020	100,000
2021	1,875,000
2022	2,500,000
2023 and thereafter	1,669,477
Total	$ 6,144,477

Line of Credit, Notes Payable_5

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt - Additional Information (Details) - USD ($)	Nov. 09, 2018	Feb. 02, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Debt Instrument, Face Amount			$ 33,000,000		$ 33,000,000
Debt Instrument, Interest Rate, Effective Percentage			5.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			56,330
Share Price			$ 1.80
Amortization of Debt Issuance Costs			$ 315,136		231,510
Long-term Line of Credit			$ 1,478,340		$ 1,469,330
Stock Issued During Period, Value, Debt Financings				$ 1,212,121
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001		$ 0.0001
Junior note payable			$ 942,214		$ 926,211
Debt Issuance Costs, Net			$ 2,207,759		$ 2,145,608
Line of Credit Facility, Increase (Decrease), Net	$ 1,500,000
Comerica Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,000,000
Debt Instrument, Interest Rate, Effective Percentage			5.68%		6.52%
Amortization of Debt Issuance Costs			$ 8,785		$ 4,275
Debt Instrument, Basis Spread on Variable Rate			3.00%
Line of Credit Facility, Expiration Date			Jan. 1, 2020
Long-term Line of Credit			$ 1,500,000		1,500,000
Debt Issuance Costs, Gross			30,445		34,945
Unsecured Promissory Notes One [Member]
Debt Instrument, Face Amount		4,500,000
Miichaelson Senior Secured Term Promissory [Member]
Debt Instrument, Face Amount		$ 5,000,000	$ 5,000,000
Debt Instrument, Interest Rate, Stated Percentage		10.25%
Debt Instrument, Maturity Date			Feb. 2, 2023
Debt Instrument, Unamortized Discount, Noncurrent			$ 418,363		223,443
Amortization of Debt Issuance Costs			85,892		51,170
Debt Issuance Costs, Gross			211,187
Stock Issued During Period, Shares, Debt Financings		320,000
Stock Issued During Period, Value, Debt Financings			1,212,121
Debt Instrument, Periodic Payment, Principal		$ 625,000
Junior Promissory Note [Member]
Amortization of Debt Issuance Costs			$ 33,560		$ 17,557
Junior note payable		1,044,477
Debt Issuance Costs, Net		135,823
Maximum [Member]
Debt Instrument, Interest Rate, Effective Percentage			4.99%
Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage			1.90%
Unsecured Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage			10.00%
Debt Instrument, Maturity Date			Jan. 1, 2020
Series C Preferred Stock [Member]
Debt Instrument, Face Amount		544,777
Debt Conversion, Original Debt, Amount		$ 4,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.0001
Preferred Stock, Dividend Rate, Percentage		10.25%

Entsorga West Virginia, LLC W_3

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds - Future Sinking Fund Payment (Details)	9 Months Ended
	Sep. 30, 2019USD ($)
Debt Instrument, Sinking Fund Payment	$ 33,000,000
Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,390,000
Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	1,470,000
Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	1,175,000
Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	28,965,000
2016 Issue 2026 Series [Member]
Debt Instrument, Sinking Fund Payment	7,535,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,160,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	1,215,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	900,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	4,260,000
2016 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2018 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	8,000,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	230,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	255,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	275,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	$ 7,240,000

Entsorga West Virginia, LLC W_4

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds - Additional Information (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018	Dec. 31, 2016	Nov. 01, 2018
Debt Instrument, Face Amount	$ 33,000,000	$ 33,000,000
Unamortized Debt Issuance Expense	2,207,759	2,145,608
Amortization of Debt Issuance Costs	315,136	231,510
Debt Issuance Costs, Net	$ 2,207,759	2,145,608
Financial Standby Letter of Credit [Member]
Debt Instrument, Collateral Amount				$ 1,250,000
WVEDA Bonds [Member]
Debt Instrument, Face Amount			$ 25,000,000
Series One [Member] | WVEDA Bonds [Member]
Debt Instrument, Face Amount			$ 7,535,000
Debt Instrument, Interest Rate, Stated Percentage			6.75%
Debt Instrument, Maturity Date			Feb. 1, 2026
Series Two [Member] | WVEDA Bonds [Member]
Debt Instrument, Face Amount			$ 17,465,000
Debt Instrument, Interest Rate, Stated Percentage			7.25%
Debt Instrument, Maturity Date			Feb. 1, 2036
Series Three [Member] | WVEDA Bonds [Member]
Debt Instrument, Face Amount		$ 8,000,000
Debt Instrument, Interest Rate, Stated Percentage		8.75%
Debt Instrument, Maturity Date		Feb. 1, 2036

Equity and Equity Transaction_2

Equity and Equity Transactions (Details) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Preferred stock,Authorized shares	3,179,120	3,159,120
Preferred Stock, Shares Outstanding	856,181	1,155,333
Series A Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	333,401
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	145,312	163,312
Series B Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	1,111,200
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	1,000,000	1,000,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 10
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	20,000	20,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 100
Preferred Stock, Shares Outstanding	18,850	0
Series E Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	714,519	714,519
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 2.64
Preferred Stock, Shares Outstanding	264,519	564,519

Equity and Equity Transaction_3

Equity and Equity Transactions - Warrants (Details) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25
Class of Warrant or Right, Outstanding	4,674,261	4,201,736
Weighted Average Price per Share	$ 1.80
2020
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.50
Class of Warrant or Right, Outstanding	22,860
Weighted Average Price per Share	$ 3.50
2021
Class of Warrant or Right, Outstanding	1,768,516
Weighted Average Price per Share	$ 3.25
2022
Class of Warrant or Right, Outstanding	1,699,861
Weighted Average Price per Share	$ 2.60
2023
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	740,749
Weighted Average Price per Share	$ 1.80
2024
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	385,945
Weighted Average Price per Share	$ 1.80
2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25
Class of Warrant or Right, Outstanding	56,330
Weighted Average Price per Share	$ 2.25
Maximum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.30
Maximum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	5
Minimum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	1.80
Minimum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80

Equity and Equity Transaction_4

Equity and Equity Transactions - Outstanding Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2019shares
Equity and Equity Transactions
Outstanding Beginning Balance	4,201,736
Issued	442,275
Issued as a result of common stock offering at $1.80 per share	30,250
Exercised	0
Expired	0
Outstanding Ending Balance	4,674,261

Equity and Equity Transaction_5

Equity and Equity Transactions - Additional Information (Details) - USD ($)	Sep. 26, 2019	Sep. 09, 2019	Jun. 20, 2019	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 2.25	$ 2.25
Preferred Stock, Shares Authorized				10,000,000	10,000,000		10,000,000
Class of Warrant or Right, Outstanding				4,674,261	4,674,261		4,201,736
Issuance of registered common shares, net of offering costs (in shares)		1,877,666
Dividends Payable				$ 1,018,375	$ 1,018,375
Common Stock, Shares Authorized				50,000,000	50,000,000		50,000,000
Common stock, par value	$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001		$ 0.0001
Common Stock, Shares, Issued				17,163,400	17,163,400		14,802,956
Description of Equity Method Investment Ownbership Percentage					The consolidated financial statements include less than 100% owned and controlled subsidiaries
Equity Method Investment, Description of Principal Activities					include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries
Preferred stock, Designated shares				3,179,120	3,179,120		3,159,120
Preferred Stock, Value, Subscriptions			$ 1,885,000
Price per common share				$ 1.80	$ 1.80
Gross proceeds of the offering					$ 3,379,799
Placement fees					195,461
Legal fees					135,359
Regulatory filing fees					8,000
Other costs					5,422
Net proceeds of the offering				$ 3,035,557	$ 3,035,557	$ 0
Warrants issued				56,330	56,330
Class of Warrant or Right Percentage of Securities Called by Each Warrant or Right			50.00%
Class of Warrant or Right				4,674,261	4,674,261		4,201,736
Number of shares issued upon conversion		50,000		90,000	90,000	433,445
Value of shares issued for payment of accrued dividend	$ 50,000
Number of shares issued for payment of accrued dividend	27,778
Warrants modification					$ 49,160	$ 0
Warrants to acquire shares of common stock				56,330	56,330
Exercise price of warrants				$ 2.25	$ 2.25
Value of warrants after revaluation		$ 405,324
Volatility
Warrants, measurement input		50.56
Risk free rate
Warrants, measurement input		1.51
Confidentially marketed public offering
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.80
Price per common share		$ 1.80
Warrants issued		1,992,325
Number of warrants issued		70
Warrants to acquire shares of common stock		1,992,325
Exercise price of warrants		$ 1.80
warrants [Member]
Warrants issued			116,651
Warrants to acquire shares of common stock			116,651
Series D Convertible Preferred Stock [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 3.50	$ 3.50
Preferred Stock, Stated Value				$ 100	$ 100
Debt Instrument, Convertible, Conversion Price			$ 3.50
Preferred Stock, Dividend Rate, Percentage					9.00%
Issuance of registered common shares, net of offering costs (in shares)			18,850
Preferred stock, Designated shares				20,000	20,000		20,000
Exercise price of warrants				$ 3.50	$ 3.50
Series D Convertible Preferred Stock [Member] | Five Year Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 3.50
Class of Warrant or Right, Outstanding			269,296
Class of Warrant or Right			269,296
Stock Price, Maximum			$ 1.88
Stock Price, Minimum			$ 2.70
Standard Deviation Volatility, Maximum			44.55%
Standard Deviation Volatility, Minimum			46.38%
Risk-free Interest Rate, Maximum			1.74%
Risk-free Interest Rate, Minimum			2.56%
Allocated Fair value Of the Warrant			$ 190,299
Exercise price of warrants			$ 3.50
Series D Convertible Preferred Stock [Member] | warrants [Member]
Warrants issued			2.25
Standard Deviation Volatility			46.23%
Risk-free Interest Rate			1.89%
Warrants to acquire shares of common stock			2.25
Series A preferred stock [Member]
Number of shares converted		18,000
Option to redeem share as a percentage of offering		50.00%
Series A preferred stock [Member] | warrants [Member]
Warrants term		1 year
Warrants modification		$ 49,160

Equity Incentive Plans - Compen

Equity Incentive Plans - Compensation Expenses Related to Stock Options (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Stock options	$ 31,323	$ 68,264	$ 104,075	$ 115,530
Restricted stock	178,262	262,064	637,113	369,714
Total	209,585	330,328	741,188	485,244
Share-based Compensation	209,585	330,328	741,188	485,244
Rental Service And Maintenance [Member]
Total	3,353	8,406	12,426	17,075
Share-based Compensation	3,353	8,406	12,426	17,075
Selling, General and Administrative Expenses [Member]
Total	206,232	321,922	728,762	468,169
Share-based Compensation	$ 206,232	$ 321,922	$ 728,762	$ 468,169

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted Stock (Details)	9 Months Ended
	Sep. 30, 2019shares
Equity Incentive Plans
Unvested balance at beginning	742,741
Grants	0
Forfeited	(40,120)
Vested	(295,053)
Unvested balance at end	407,568

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 07, 2017	Dec. 31, 2015
Stock Issued During Period, Value, Stock Options Exercised	$ 61,977		$ 61,977
Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Value, Stock Options Exercised		$ 0
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					750,000
Executive Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				1,000,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - Consulting Services Related Matters [Member] - USD ($)	Apr. 23, 2019	Sep. 30, 2019
Stock Issued During Period, Shares, Other	75,000
Tusk Ventures LLC [Member]
Loss Contingency, Damages Sought, Value		$ 250,000

Leases (Details)

Leases (Details)	Sep. 30, 2019USD ($)
Leases
2019 (remaining)	$ 51,406
2020	146,926
2021	109,000
2022	113,000
2023 and thereafter	3,093,750
Total	3,514,082
Less imputed interest	(2,431,140)
Present value of lease liabilities	$ 1,082,942

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Lessee, Lease, Description [Line Items]
Operating Lease Renewal Term		5 years		5 years
Operating Leases, Rent Expense	[1]	$ 210,709	$ 0	$ 354,733	$ 0
Operating Lease, Liability, Current		169,575		169,575
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability				1,045,755
Operating Lease, Payments		$ 51,406		$ 143,597
Land Lease [Member]
Lessee, Lease, Description [Line Items]
Operating Lease Initial Term		30 years		30 years
Leases Utilization Percentage				11.00%
Other Lease [Member]
Lessee, Lease, Description [Line Items]
Leases Utilization Percentage				10.25%
Research And Development Lease [Member]
Lessee, Lease, Description [Line Items]
Operating Leases, Rent Expense		$ 55,356	$ 37,874	$ 166,067	$ 108,182
Operating Lease, Weighted Average Remaining Lease Term		25 years 1 month 6 days		25 years 1 month 6 days
[1]	Disposal costs - A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Assets:
Accounts receivable		$ 1,520,001		$ 1,520,001		$ 403,298
Liabilities:
Accounts payable		4,200,518		4,200,518		1,310,998
Accrued interest payable		705,384		705,384		959,927
Long term accrued interest		1,390,380		1,390,380		1,305,251
Notes payable		100,000		100,000		0
Advance from related party		210,000		210,000		0
Other:
Project fees	[1]	590,262	$ 0	831,274	$ 0
S, G & A - Rent expense	[2]	210,709	0	354,733	0
Cost of revenues - Rent expense	[3]	24,537	30,784	73,611	78,564
Interest expense		76,611	57,890	194,266	262,089
Cost of revenue, inventory or equipment on operating leases acquired	[4]	0	2,720	0	14,525
Related Party [Member]
Assets:
Accounts receivable	[1],[5],[6]	915,171		915,171		168,588
Intangible assets, net, included in other assets	[4]	45,449		45,449		83,933
Liabilities:
Accounts payable	[2],[3],[4],[7]	1,563,705		1,563,705		160,761
Accrued interest payable		61,632		61,632		46,796
Long term accrued interest	[8]	1,390,380		1,390,380		1,305,251
Advance from related party	[9]	210,000		210,000		0
Junior promissory note	[8]	942,214		942,214		926,211
Other:
Line of credit guarantee	[10]	1,478,340		1,478,340		$ 1,469,330
S, G & A - Consulting expense [Member]
Other:
S, G & A - Consulting expense	[3],[4],[7]	110,650	50,000	258,050	150,000
Debt guarantee fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	[10]	16,875	31,250	50,625	52,083
Management Advisory Fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	[5],[6]	$ 250,000	$ 360,393	$ 750,000	$ 794,718
[1]	HEBioT Disposal Revenues - Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility.
[2]	Disposal costs - A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility.
[3]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of September 30, 2019 under these operating leases total $67,082, with $25,156 due in 2019 and $41,926 due in 2020.
[4]	Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market.
[5]	Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG.
[6]	Project Fees - In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations.
[7]	Business Services Fees - A GMG subsidiary provides certain general management and administrative support to the HEBioT facility.
[8]	Junior Promissory Note - See Note 10.
[9]	Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.
[10]	Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt.

Related Party Transactions - Ex

Related Party Transactions - Expenses (Details) - USD ($)		Oct. 17, 2018	Feb. 02, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				5.00%		5.00%
2019 (remaining)				$ 51,406		$ 51,406
Line of Credit Fee Percentage			4.50%
Debt Conversion, Converted Instrument, Amount						0	$ 9,090,375
Operating leases total				3,514,082		3,514,082
Operating Leases, Rent Expense	[1]			210,709	$ 0	354,733	$ 0
2020				146,926		146,926
2021				$ 109,000		$ 109,000
Preferred Stock, Par or Stated Value Per Share			$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Total				$ 3,514,082		$ 3,514,082
Series C Preferred Stock [Member]
Related Party Transaction [Line Items]
Debt Conversion, Original Debt, Amount			$ 4,000,000
Preferred Stock, Dividend Rate, Percentage			10.25%
Preferred Stock, Par or Stated Value Per Share			$ 0.0001
Facility Lease [Member]
Related Party Transaction [Line Items]
2019 (remaining)				25,156		25,156
Operating leases total				67,082		67,082
2020				41,926		41,926
Total				$ 67,082		$ 67,082
Amended [Member]
Related Party Transaction [Line Items]
Debt Instrument, Periodic Payment		$ 75,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				13.00%		13.00%
Mr. Koh [Member]
Related Party Transaction [Line Items]
Debt Instrument, Periodic Payment						$ 200,000
[1]	Disposal costs - A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility.

Related Party Transaction - Add

Related Party Transaction - Additional Information (Details)	Feb. 02, 2016USD ($)	Nov. 30, 2015USD ($)$ / sharest	Sep. 30, 2019USD ($)
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage			5.00%
Business Service Agreement [Member]
Related Party Transaction [Line Items]
Term of service agreement	10 years
Term of service agreement renewal	5 years
Consideration payable on service agreement during construction period	$ 72,000
Consideration payable on service agreement on commencement of operation	$ 367,600
Solid Waste Delivery or Disposal Agreement [Member]
Related Party Transaction [Line Items]
Delivery of minimum solid waste in tonnes based on agreement | t		52,000
Maximum amount of Solid waste accepted | t		66,250
Weighted average price per ton on solid waste | $ / shares		56.37
Penalty on shortfall of minimum solid waste delivery per ton		$ 20
Penalty on refused minimum solid waste delivery per ton		$ 20
Refuel America LLC [Member]
Related Party Transaction [Line Items]
Percentage of interest acquired			40.00%
Consideration Paid			$ 3,500,000
Additional investment in refuel			$ 2,100,000

Supplemental Consolidated Sta_3

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 09, 2019	Dec. 31, 2018	Dec. 31, 2017
Changes in operating assets and liabilities:
Accounts receivable	$ (1,335,024)	$ (90,884)
Inventory	(181,979)	(905,043)
Prepaid expenses and other assets	(3,300)	(14,216)
Accounts payable	3,111,285	336,315
Accrued interest payable	(260,046)	377,709
Accrued expenses	(2,504,724)	(350,867)
Deferred revenue	(1,131)	15,206
Customer deposits	37,109	(16,937)
Net change in operating assets and liabilities	(1,137,810)	(648,717)
Supplementary cash flow information:
Interest	2,625,018	378,431
Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	259,449	437,223
Common stock issued in settlement of accrued interest	0	915,700
Common stock issued in acquisition of Gold Medal Group, LLC	0	2,250,000
Conversion of notes into common stock	0	9,090,375
Conversion of Series B preferred stock into common stock	0	1,767,371
In-Kind payments by investors for common and preferred stock	$ 0	$ 341,998
Number of shares issued upon conversion	90,000	433,445	50,000
Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable	$ 0	$ 5,319,777
Accrual of Series A preferred stock dividends	140,631	66,958
Payment of Series A preferred stock dividends in common stock	50,000	0
Reconciliation of Cash and Restricted Cash:
Cash	3,434,089	384,403		$ 2,410,709
Restricted cash (short term)	1,128,716	0		4,195,148
Restricted cash (non-current)	2,544,948	0
Total cash and restricted cash at the end of the period	$ 7,107,753	$ 384,403		$ 9,126,380	$ 901,112

Recent Accounting Standards (De

Recent Accounting Standards (Details)	Jan. 01, 2019
Recent Accounting Standards
Percentage Of Changes In Assets And Liabilities On Adoption Of New Accounting Principle	2.00%

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Details) - USD ($)	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018
Current Assets
Cash	$ 3,434,089		$ 2,410,709
Restricted Cash	1,128,716		4,195,148
Other current assets	2,118,431		969,571
Current Assets	6,681,236		7,575,428
Restricted cash	2,544,948		2,520,523
HEBioT facility	36,806,051		33,104,007
Other fixed assets	1,711,208		1,797,915
Operating lease right of use assets	970,895		0
MBT facility development and license costs	8,058,767		8,475,408
Intangible assets, net and investment in subsidiaries	0		1,771,316
Goodwill.	58,000		58,000
Other assets	58,949		13,500
Total Assets	56,890,054		55,316,097
Liabilities, Current [Abstract]
Line of credit	1,478,340		1,469,330
Current portion of WV EDA Bonds	1,390,000
Other current liabilities	6,175,870		5,740,493
Current liabilities	9,044,210		7,209,823
Notes payable and other debts	5,032,423		4,890,322
Accrued interest	1,390,380		1,305,251
Non-current lease liabilities	913,367
WV EDA bonds	29,717,377		31,085,902
Total Liabilities	46,097,757		44,491,298
Redeemable preferred stock	726,553		816,553
Stockholders' equity :
Attributable to parent	3,922,118	$ 1,880,500	3,405,551	$ 2,981,820	$ 4,246,792
Attributable to non-controlling interests	6,143,626	$ 6,871,963	6,602,695
Stockholders' equity	10,065,744		10,008,246
Total liabilities and stockholders' equity	56,890,054		55,316,097
Consolidation, Eliminations [Member]
Current Assets
Cash	0		0
Restricted Cash	0		0
Other current assets	(189,551)		0
Current Assets	(189,551)		0
Restricted cash	0		0
HEBioT facility	0		0
Other fixed assets	0		0
Operating lease right of use assets	0
MBT facility development and license costs	0		0
Intangible assets, net and investment in subsidiaries	(10,278,558)		(5,854,952)
Goodwill.	0		0
Other assets	0		0
Total Assets	(10,468,109)		(5,854,952)
Liabilities, Current [Abstract]
Line of credit	0		0
Current portion of WV EDA Bonds	0
Other current liabilities	(189,551)		0
Current liabilities	(189,551)		0
Notes payable and other debts	0		0
Accrued interest	0		0
Non-current lease liabilities	0
WV EDA bonds	0		0
Total Liabilities	(189,551)		0
Redeemable preferred stock	0		0
Stockholders' equity :
Attributable to parent	0		(5,854,952)
Attributable to non-controlling interests	(10,278,558)		0
Stockholders' equity	(10,278,558)		(5,854,952)
Total liabilities and stockholders' equity	(10,468,109)		(5,854,952)
Entsorga West Virginia LLC [Member]
Current Assets
Cash	34,335		0
Restricted Cash	1,128,716		4,195,148
Other current assets	899,102		0
Current Assets	2,062,153		4,195,148
Restricted cash	2,544,948		2,520,523
HEBioT facility	36,806,051		33,104,007
Other fixed assets	0		0
Operating lease right of use assets	889,791
MBT facility development and license costs	1,837,000		1,890,000
Intangible assets, net and investment in subsidiaries	0		0
Goodwill.	58,000		58,000
Other assets	0		0
Total Assets	44,197,943		41,767,678
Liabilities, Current [Abstract]
Line of credit	0		0
Current portion of WV EDA Bonds	1,390,000
Other current liabilities	4,153,724		3,708,410
Current liabilities	5,543,724		3,708,410
Notes payable and other debts	0		0
Accrued interest	0		0
Non-current lease liabilities	913,367
WV EDA bonds	29,717,377		31,085,902
Total Liabilities	36,174,468		34,794,312
Redeemable preferred stock	0		0
Stockholders' equity :
Attributable to parent	0		5,854,952
Attributable to non-controlling interests	8,023,475		1,118,414
Stockholders' equity	8,023,475		6,973,366
Total liabilities and stockholders' equity	44,197,943		41,767,678
Parent Company [Member]
Current Assets
Cash	3,399,754		2,410,709
Restricted Cash	0		0
Other current assets	1,408,880		969,571
Current Assets	4,808,634		3,380,280
Restricted cash	0		0
HEBioT facility	0		0
Other fixed assets	1,711,208		1,797,915
Operating lease right of use assets	81,104
MBT facility development and license costs	6,221,767		6,585,408
Intangible assets, net and investment in subsidiaries	10,278,558		7,626,268
Goodwill.	0		0
Other assets	58,949		13,500
Total Assets	23,160,220		19,403,371
Liabilities, Current [Abstract]
Line of credit	1,478,340		1,469,330
Current portion of WV EDA Bonds	0
Other current liabilities	2,211,697		2,032,083
Current liabilities	3,690,037		3,501,413
Notes payable and other debts	5,032,423		4,890,322
Accrued interest	1,390,380		1,305,251
Non-current lease liabilities	0
WV EDA bonds	0		0
Total Liabilities	10,112,840		9,696,986
Redeemable preferred stock	726,553		816,553
Stockholders' equity :
Attributable to parent	3,922,118		3,405,551
Attributable to non-controlling interests	8,398,709		5,484,281
Stockholders' equity	12,320,827		8,889,832
Total liabilities and stockholders' equity	$ 23,160,220		$ 19,403,371

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information - Statement of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues	$ 1,426,775	$ 1,088,082	$ 3,212,689	$ 2,642,946
Operating Expenses [Abstract]
Selling, general and administrative	1,449,545		5,450,282
Depreciation and amortization	611,368		1,350,780
Total operating expenses	3,042,020	2,265,360	8,674,904	6,378,781
Loss from operations	(1,615,245)	(1,177,278)	(5,462,215)	(3,735,835)
Other expenses	419,565	819,849	1,721,434	8,978,056
Net loss	(2,034,810)	(1,997,127)	(7,183,649)	(12,713,891)
Consolidation, Eliminations [Member]
Revenues	0		0
Operating Expenses [Abstract]
Selling, general and administrative	0		0
Depreciation and amortization	0		0
Total operating expenses	0		0
Loss from operations	0		0
Other expenses	0		86,362
Net loss	0		(86,362)
Entsorga West Virginia LLC [Member]
Revenues	609,905		886,947
Operating Expenses [Abstract]
Selling, general and administrative	246,026		771,867
Depreciation and amortization	490,469		980,937
Total operating expenses	1,523,175		3,061,980
Loss from operations	(913,270)		(2,175,033)
Other expenses	600,402		1,361,221
Net loss	(1,513,672)		(3,536,254)
Parent Company [Member]
Revenues	816,870		2,325,742
Operating Expenses [Abstract]
Selling, general and administrative	1,203,519		4,678,415
Depreciation and amortization	120,899		369,843
Total operating expenses	1,518,845		5,612,924
Loss from operations	(701,975)		(3,287,182)
Other expenses	(180,837)		273,851
Net loss	(521,138)		(3,561,033)
HEBioT (related entity)
Cost of revenue	786,680	0	1,309,176	0
HEBioT (related entity) | Consolidation, Eliminations [Member]
Cost of revenue	0		0
HEBioT (related entity) | Entsorga West Virginia LLC [Member]
Cost of revenue	786,680		1,309,176
HEBioT (related entity) | Parent Company [Member]
Cost of revenue	0		0
Rental, service and maintenance [Member]
Cost of revenue	176,651	241,875	508,164	644,832
Rental, service and maintenance [Member] | Consolidation, Eliminations [Member]
Cost of revenue	0		0
Rental, service and maintenance [Member] | Entsorga West Virginia LLC [Member]
Cost of revenue	0		0
Rental, service and maintenance [Member] | Parent Company [Member]
Cost of revenue	176,651		508,164
Equipment sales [Member]
Cost of revenue	17,776	$ 155,651	56,502	$ 355,154
Equipment sales [Member] | Consolidation, Eliminations [Member]
Cost of revenue	0		0
Equipment sales [Member] | Entsorga West Virginia LLC [Member]
Cost of revenue	0		0
Equipment sales [Member] | Parent Company [Member]
Cost of revenue	$ 17,776		$ 56,502

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information - Statement of Cash Flow (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Cash flows used in operating activities:
Net loss	$ (2,034,810)	$ (1,997,127)	$ (7,183,649)	$ (12,713,891)
Adjustments to reconcile net loss to net cash used in operations			2,303,947
Changes in operating assets and liabilities			(1,137,810)	(648,717)
Net cash used in operations			(6,017,512)	(4,386,230)
Cash flows used in investing activities:
Construction in process and acquisitions of property and equipment			(4,619,883)
Capital contribution to Entsorga West Virginia, LLC			0
Other investing activities			2,256,987
Net cash used in investing activities			(2,362,896)	(337,662)
Cash flows from financing activities:
Issuances of debt and equity			6,418,057
Repayments of debt			(6,846)
Deferred financing costs incurred			(62,151)	(237,187)
Net cash provided by financing activities			6,349,060	4,162,424
Effect of exchange rate on cash			12,721	44,759
Cash - beginning of period (restricted and unrestricted)			9,126,380	901,112
Cash - end of period (restricted and unrestricted)	7,107,753	$ 384,403	7,107,753	$ 384,403
Consolidation, Eliminations [Member]
Cash flows used in operating activities:
Net loss	0		(86,362)
Adjustments to reconcile net loss to net cash used in operations			86,362
Changes in operating assets and liabilities			0
Net cash used in operations			0
Cash flows used in investing activities:
Construction in process and acquisitions of property and equipment			0
Capital contribution to Entsorga West Virginia, LLC			4,586,362
Other investing activities			0
Net cash used in investing activities			4,586,362
Cash flows from financing activities:
Issuances of debt and equity			(4,586,362)
Repayments of debt			0
Deferred financing costs incurred			0
Net cash provided by financing activities			(4,586,362)
Effect of exchange rate on cash			0
Cash - beginning of period (restricted and unrestricted)			0
Cash - end of period (restricted and unrestricted)	0		0
Entsorga West Virginia LLC [Member]
Cash flows used in operating activities:
Net loss			(3,536,254)
Adjustments to reconcile net loss to net cash used in operations			1,064,563
Changes in operating assets and liabilities			(440,212)
Net cash used in operations			(2,911,903)
Cash flows used in investing activities:
Construction in process and acquisitions of property and equipment			(4,619,981)
Capital contribution to Entsorga West Virginia, LLC			0
Other investing activities			0
Net cash used in investing activities			(4,619,981)
Cash flows from financing activities:
Issuances of debt and equity			4,586,362
Repayments of debt			0
Deferred financing costs incurred			(62,151)
Net cash provided by financing activities			4,524,211
Effect of exchange rate on cash			0
Cash - beginning of period (restricted and unrestricted)			6,715,672
Cash - end of period (restricted and unrestricted)	3,707,999		3,707,999
Parent Company [Member]
Cash flows used in operating activities:
Net loss	(521,138)		(3,561,033)
Adjustments to reconcile net loss to net cash used in operations			1,153,022
Changes in operating assets and liabilities			(697,598)
Net cash used in operations			(3,105,609)
Cash flows used in investing activities:
Construction in process and acquisitions of property and equipment			98
Capital contribution to Entsorga West Virginia, LLC			(4,586,362)
Other investing activities			2,256,987
Net cash used in investing activities			(2,329,277)
Cash flows from financing activities:
Issuances of debt and equity			6,418,057
Repayments of debt			(6,846)
Deferred financing costs incurred			0
Net cash provided by financing activities			6,411,211
Effect of exchange rate on cash			12,721
Cash - beginning of period (restricted and unrestricted)			2,410,708
Cash - end of period (restricted and unrestricted)	$ 3,399,754		$ 3,399,754